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In clinical trials, it is important to understand and characterize disease and treatment response
heterogeneity among patients so that precision medicine can particularly target certain subsets of
patients, defined by baseline characteristics. Feature variables, such as demographic characteristics,
genetic, genomic and environmental information, combined with a patient’s survival outcome, can
be used to explore such latent heterogeneity.
In the first project, we propose a mixture model to explore each patient’s latent survival pattern,
where the mixing probabilities for latent groups are modeled through a multinomial distribution. The
Bayesian information criterion (BIC) is used for selecting the number of latent groups. Furthermore,
we incorporate variable selection with the adaptive lasso into inference so that only a few feature
variables will be selected to characterize the latent heterogeneity. We show that our adaptive lasso
estimator has oracle properties when the number of parameters diverges with the sample size. The
finite sample performance is evaluated by simulation studies under different scenarios, and the
proposed method is illustrated by the data from a breast cancer clinical trial (IBCSG) and the data
of the assay of free light chain.
In the second project, we develop a mixture survival tree model for direct risk classification.
We assume that the patients can be classified into a pre-specified number of risk groups, where
each group has distinct survival profile. Our proposed tree-based method is devised to estimate
latent group membership using the Expectation Maximization (EM) algorithm. The observed data
log-likelihood function is used as the splitting criterion in recursive partitioning. We examine
the monotone likelihood property of the proposed algorithm. The finite sample performance is
iii
evaluated by extensive simulation studies and the proposed method is illustrated by a case study in
breast cancer.
In the third project, we study the unobserved heterogeneity in patient’s treatment response. We
consider a semi-parametric approach to directly classify patients into different latent subgroups
where each subgroup of patients demonstrates a distinct average treatment effect. A random forest
algorithm is developed to learn how the baseline covariates determine the unobserved heterogeneity
in patients. In each individual tree, the EM algorithm is incorporated to handle the unobserved
subgroup membership. The observed data log-likelihood function is used as the splitting criterion in
recursive partition. A variable importance measurement is derived to facilitate identifying important
features related to subgroup membership assignment. We evaluate the numeric performance of
our proposed random forest model via extensive simulation studies and provide an application to a
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CHAPTER 1: INTRODUCTION
In the fight against diseases such as cancers, one drug hardly demonstrates benefits for a
large population of patients. With patients’ different survival experiences and/or an overall non-
significant treatment effect observed in practice, an exploration in the overall population for potential
heterogeneity is fundamental in clinical trials. Particularly, the discovery of subpopulations with
different survival risks or distinct treatment responses enables the development of tailored therapy
for a subgroup of patients. With the rapid growth in science and technology, more health-related
data become available. The development of statistical learning methods to identify latent groups
of patients and study the homogeneity of patients from the same group defined by individual
characteristics attracts more attention. The goal of this dissertation is to discover latent subgroups
using survival outcome and baseline characteristics. By the three research topics, we propose
various approaches to assist the latent subgroup discovery under different scenarios.
First, we focus on variable selection procedure in the latent subgroup identification using sur-
vival outcome. The survival distribution is modeled parametrically. We assume that patients in each
subgroup have different survival experience and the latent subgroup membership is determined by
baseline covariates. The EM algorithm is applied to deal with the unobserved subgroup membership.
Important variables are selected by introducing adaptive lasso penalty. We show the oracle property
for our proposed estimator when the number of covariates diverges with the sample size. Simulation
studies are used to evaluate the performance of our proposed methodology and our method is
illustrated using two data examples.
Second, we explore the latent prognosis groups in a nonparametric manner. We develop
a tree-based algorithm to explore different survival risk groups. We aim to provide a direct
classification on patients to avoid concerns related to the lack of statistical power. More specifically,
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we recursively partition the covariate space to learn the relationship between latent subgroup
membership assignment and baseline covariates. The EM algorithm is embedded in each splitting
and the observed data loglikelihood function is used as the splitting criterion. The survival risk
classification is based on the posterior probabilities of a patient belonging to each latent subgroup,
which is calculated along the tree growth. We examine the monotone likelihood property of the
proposed algorithm. Extensive simulation studies are performed to evaluate our method. We apply
the proposed method on a clinical trial of breast cancer.
Lastly, we extend the tree-based method for survival risk classification to the scenario that
heterogeneous treatment effects are present in the data. The survival distribution is modeled semi-
parametrically through a cox model. The latent subgroup are defined by treatment and baseline
covariates. The differences among subgroups are due to patients’ different treatment responses. A
random forest model based on ensemble of individual trees is proposed to enhance the predictive
performance. We derive a variable importance measurement to identify importance variables that
are predictive of latent subgroup membership. We use simulations and an analysis on a phase III
clinical trial in patients with hematological malignancies to illustrate the application of our proposed
method.
The remainder of this dissertation is organized as follows. In Chapter 2, we introduce related
concepts and works that are essential to the development of this dissertation. The aforementioned
three research topics are covered in chapters 3, 4 and 5 respectively. Chapter 6 discusses extension
and future research directions of the three topics. Technical details and references of the entire
dissertation are followed.
2
CHAPTER 2: LITERATURE REVIEW
In this Chapter, we review related concepts and existing representative works that are essential
to the development of this dissertation. In Section 2.1, we review a number of literature on the
statistical methods to handle and identify heterogeneity with the time-to-event data using the mixture
model framework. In Section 2.2, a large set of approaches in tackling high-dimensional data will
be discussed. In Section 2.3, with the focus of tree-based methods, we introduce the main semi-
parametric and non-parametric approaches in the context of survival outcomes. In Section 2.4, we
go through the representative works that investigate heterogeneous treatment effects in the data.
2.1 Mixture model in Survival Analysis
Survival analysis is a popular research field in statistics, which models the expected duration
of time associated with the occurrence of one or more events. It is widely used in cancer clinical
research and drug/vaccine clinical trials. In the past several decades, it is of great interest to identify
the unobserved heterogeneity in survival data, where the patients’ heterogeneity may be associated
with different survival profiles and/or different treatment responses. In the broad literature, finite
mixture models is a popular direction to deal with the heterogeneity in the data.
In the field of survival analysis, a finite mixture model is directly applicable in the case that one
parametric distribution cannot adequately describe the distribution of survival time. An example is
from McGiffin et al. (1992), where the survival time of a patient after major cardiac surgery could
be decomposed into three phases and each phase was associated different risk of death. A mixture
model consisted of three components could be applied to model the distribution of the time to death.
Another case that the finite mixture model can be employed is related to competing risks
where a patient is exposed to competing causes of failure. The mixture model can be regarded as
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an alternative to Prentice et al. (1978). Instead of considering cause-specific hazard functions to
characterize the joint distribution of the failure time and the type of failure, Larson and Dinse (1985)
proposed a parametric mixture model to analyze competing risks data where the mixing parameters
correspond to the marginal probabilities of various failure types. More specifically, they model the
number of risk-specific failures through a multinomial distribution and the probability of failing
from risk j is written via a logistic regression, given as








where D indicates the type of failure and z denotes the vector of covariates. The survival function,
given the type of failure j, is modelled as









where λj(x) is the null hazard function for failure j with covariates taking value of 0.
The finite mixture model can also be utilized to model the mixing proportion as a function of the
covariates. For example, Farewell (1982) analyzed a toxicological experiment data using mixture
models by assuming a fraction of long-term survivors, where a logistic function of covariates were
used to model the mixing components (i.e., a long-term survivor vs. early death in Farewell (1982)).
More recently, mixture models are widely used to identify and analyze latent subgroups in the
data. Altstein and Li (2013) studied a semiparametric accelerated failure time mixture model on
a latent subgroup with time-to-event data in randomized clinical trials, where the unobservable
membership in one arm of the clinical trial introduced the latency in the data. Shen and He (2015)
performed a confirmatory statistical test to examine the existence of subgroups and considered
a structured Logistic-Normal mixture model to identify a subgroup with enhanced treatment
effect. Bussy et al. (2019) proposed a Quasi-Newton Expectation Maximization algorithm to
detect patients subgroups based on discrete survival data. As technology advances, more machine
learning approaches in analyzing survival data with heterogeneity emerged and enriches the fruitful
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literature. Bennis et al. (2020) proposed a neural network architecture to estimate a finite mixture of
two-parameter Weibull distributions with right-censored data.
2.2 Variable Selection
Baseline characteristics are often considered to be predictive of the latent subgroup member-
ship. A large number of covariates, such as demographic characteristics, genetic, genomic and
environmental information, may be involved in the procedure of latent subgroup identification. It
is natural to believe that only a few covariates are truly predictive of latent subgroup membership.
Therefore, variables selection in latent subgroup identification is necessary to allow the final model
to possess good predictability and interpretability.
Various approaches of variable selection have been greatly discussed in the literature. The most
classical way to deal with high-dimensional data is to construct statistical tests. Stepwise regression
(Breaux, 1967) is the first model selection strategy. Its idea is simple and straightforward: the
subset of important variables are selected by retrieving insignificant variables or adding significant
variables based on statistical criterion. Later, many model-based statistics, including Mallow’s Cp
(Mallows, 1973), the Akaike information criterion (AIC) (Akaike, 1974), the Bayesian information
criterion (Schwarz et al., 1978) and autometrics (Hendry and Richard, 1987), are developed to
choose the best subset of variables among candidates.
In the last several decades, more advanced approaches, such as regularization approaches, have
been developed and commonly used in practice. Methods in this category involve a penalty on
parameters to introduce sparsity of covariates. The most common method is the least absolute
shrinkage and selection operator (LASSO) (Tibshirani, 1996). A L1 type penalty is imposed to the
negative log-likelihood function. Friedman et al. (2010) introduced the coordinate descent algorithm
to successively minimize along coordinate directions to find the minimum of the objective function.
Meinshausen and Bühlmann (2006) pointed out that it is possible that LASSO selects noise variables
using an optimal shrinkage parameter. So many alternative methods have been developed, including
the Bridge (Knight et al., 2000), the smoothly slipped absolute deviation penalty (SCAD) (Fan
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and Li, 2001), the adaptive LASSO (Zou, 2006), the adaptive elastic-net (Zou and Zhang, 2009).
These penalty functions are designed to impose the regression parameter estimates for unimportant
variables to zero, as a result, excluding these unimportant variables from the model. Therefore,
predicted values of the response of interest could be written as a function of a potentially smaller
number of variables. Favorable theoretical properties, including the oracle properties, for these
methods have been well established. The oracle properties refer to the consistency of selection and
asymptotic normality, with the asymptotic covariance matrix being the same as that which would be
obtained if we know the true underlying model. Thus, for large samples, oracle procedures perform
as well as if the true underlying model were known in advance.
Another category of variables selection approaches is based on screening, such as the sure
independence screening (Fan and Lv, 2008) and its extension in Fan et al. (2009). The methods in
this category is very efficient in handling very high dimensional data. The choice of the ranking
measure for screening methods plays a key role in reducing the set of candidate variables. To deliver
computational efficient and powerful results, screening methods are often combined with other
variable selection procedures: the most popular choice is regularization method in the literature.
In the context of unlabeled data or mixture models, variable selection is also greatly studied.
Law et al. (2003, 2004) discussed feature selection in Gaussian mixture-based clustering and
proposed two approaches. One is to estimate feature saliencies with the help of expectation-
maximization algorithm, and the other is carried out by a backward search scheme on the basis of
Koller and Sahami’s mutual-information-based feature relevance criterion. Raftery and Dean (2006)
investigated feature selection for model-based clustering by addressing the nested model comparison
via approximate Bayes factors. Khalili and Chen (2007) proposed a class of penalty functions to be
used for variable selection, which are counterparts of LASSO, HARD and SCAD in the context of
finite mixture regression models, labelled as MIXLASSO, MIXHARD and MIXSCAD penalties
respectively.
For data with time-to-event outcomes, Tibshirani (1997) proposed the LASSO method for
variable selection and shrinkage in Cox proportional hazards model. Fan and Li (2002) generalized
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the nonconcave penalized likelihood approach to the Cox proportional hazards model and the Cox
proportional hazards frailty model. Liu et al. (2012) extended the adaptive LASSO approach to a
Cox mixture cure model, which assumes that the subjects consist of two subpopulations: the cured
one refers to subjects who never experience the event of interest, and the other one, by contrast,
named ”non-cured”. The mixing probabilities are usually assumed to follow a logistic regression
model. The authors state that a mixture cure model, in which a Cox proportional hazard is assumed
in the latency, can be estimated iteratively in two parts: the Cox model and the logistic regression.
Hence, the adaptive LASSO procedure can be easily applied in this context.
2.3 Survival trees
Numerous studies with time-to-event data arise in various research areas. Among these studies,
the Cox proportional hazard regression model and its extensions are the most classical and widely
used methods because they simply interpret the effect of covariates and are easily employed for
inference. However, a specific link between the covariates and the response is required for the Cox
proportional hazard model. Moreover, the interaction between covariates can be incorporated into
such models but the functional form should be first specified by the user. Sometimes it is infeasible
to impose a link function and specify the functional form of covariates to build the Cox proportional
hazard model.
In this case, more flexible approaches are needed. As a result, more efforts have been devoted
to develop tree-based methods by virtual of their nonparametric nature. Tree-based methods
can automatically detect interactions based on recursive partition and offer great flexibility and
interpretability. Therefore, survival trees and forests become popular alternatives to parametric
and semi-parametric models. Additionally, decision trees can be regarded as another approach to
discover subgroups and conduct variables selection. A number of regions of the covariate space (i.e.
subgroups) are created by performing a series of binary splits. The regions of the covariate space
contain individuals who are similar with respect to the outcome of interest, i.e., their survival profile
and/or treatment responses. In this perspective, decision trees can naturally group subjects by their
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survival experience and/or treatment response given some baseline covariates, so that subgroups
can be easily discovered afterwards. In the meantime, these regions are usually defined using only a
subset of the available variables.
Classification and regression tree (CART) (Breiman et al., 1984) is proposed to handle cate-
gorical or continuous response variables using a set of covariates. The tree partition is realized
by recursively splitting the parent node into two child nodes based on some entropy measures of
impurity, and the subjects in the same node will eventually have desirable similarity in terms of the
outcome of interest. A pruning method to prevent overfitting is applied after the tree is fully grown
according to a stopping criterion.
The survival tree (Ciampi et al., 1981; Marubini et al., 1983; Gordon and Olshen, 1985) was
first developed, aiming to extend existing tree-based methods to the time-to-event data. There are
a number of discussions focusing on the splitting criterion for tree partition. The basic idea is to
maximize the within-node homogeneity and the between-node heterogeneity. Gordon and Olshen
(1985) discussed the use of the logrank statistic and a parametric likelihood ratio statistic to measure
how different between two child nodes. Many later works (Ciampi et al., 1986, 1987; Davis and
Anderson, 1989; Ciampi et al., 1988; LeBlanc and Crowley, 1993) further studied these two splitting
criteria for some specific models including the exponential model and the Cox proportional hazard
model.
A new splitting criterion based on a node deviance measure between the log-likelihoods from a
saturated model and a maximized model is introduced by LeBlanc and Crowley (1992). This work








where NT denotes the set of terminal nodes of tree T ; Sh is the set of observation labels, {i : xi ∈
Xh}, for observations in the region Xh corresponding to node h; ti and δi are the observed time and
the event status for individual i, respectively; and λh(t) and Λh(t) are the hazard and cumulative
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hazard functions for node h. λh(t) can be written as λh(t) = θhλ0(t), where θh is a nonnegative
parameter and λ0(t) is the baseline hazard. The Breslow estimator is used to approximate the
baseline cumulative hazard function. They considered the full likelihood deviance to measure the





where Lh(saturated) is the log-likelihood for the saturated model and Lh(θ̃h) is the maximized
log-likelihood when the baseline cumulative hazard is known. Their algorithm maximized the
reduction in deviance realized by the split by recursively partitioning the data.
In recent years, survival trees for time-to-event data still receive much attention. Molinaro
et al. (2004) established a unified approach to construct and select trees with censoring. Their
approach is driven by the choice of a loss function for the full (uncensored) data structure. The
median survival tree based on L1 loss function is investigated by Cho and Hong (2008). The use of
integrated absolute difference between the two children nodes survival functions as the splitting
criterion is discussed by Moradian et al. (2017). Numerous research extended the squared error loss
in regression trees to survival data with censoring (Molinaro et al., 2004; Steingrimsson et al., 2016,
2019). Sun et al. (2019) incorporated the time-dependent receiver operating characteristics (ROC)
curves into survival trees. With this method, the ROC curves is utilized to guide the tree-building
algorithm and evaluate the performance of survival trees.
2.4 Subgroup Analysis
With the thriving of the biology, pharmacology and technology, more personalized medicine and
targeted treatments are favorable. Subgroup analysis aims to reveal potential variation in treatment
effect in different subgroups of individuals. It is of great interest to explore such heterogeneity and
identify different subgroups of patients who respond to the treatment differently. So personalized
treatment could be applied afterwards. Increasing discussions and attention have been received in
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the area of subgroup analysis using statistical methods. Pocock et al. (2002) investigated the use
of patient characteristics in clinical trials by surveying 50 reports of clinical trials. The difficulties
in conducting subgroup analysis and the need for the appropriate statistical procedures in medical
decision making are well discussed. Tanniou et al. (2016) defined four purposes for subgroup
analyses in phase III clinical trials through a comprehensive review of 1857 papers in this field.
They argued that subgroup analysis plays a fundamental role in the investigation of the consistency of
treatment effects across subgroups, the exploration of the treatment effect across different subgroups
within an overall non-significant trial, the evaluation of the safety profiles in a limited number of
subgroups, and the establishment of the efficacy in the targeted subgroup.
A large number of studies focus on identifying and assessing the heterogeneity of treatment
effect in clinical trials based on statistical hypothesis testing. For example, Song and Chi (2007)
proposed a general statistical testing procedure, which offers the optimal power and strong control
of the familywise Type I error rate. Their proposed framework is applicable to the cases that certain
subgroups in clinical trials are already discovered. Michiels et al. (2011) studied treatment-effect-
modifying-biomarkers in a phase III clinical trial with a survival endpoint to identify different
treatment effects in subgroups that are associated with multiple specific biomarkers. Five different
permutation test procedures were considered in their work to ascertain the existence of a subgroup
of patients responding to treatment differently. Many other works, including Alosh and Huque
(2009); Chen and Beckman (2009); Millen et al. (2012); Kovalchik et al. (2013); Krisam and Kieser
(2014), are also devoted to develop statistical methodology for evaluating heterogeneous treatment
effects in subgroups.
Unlike aforementioned methods within the scope of statistical testing, another research area
in subgroup analysis, with the goal of exploring certain patterns within the overall population, has
drawn wide attention for decades. This purpose can be formulated as a classification problem
and established by extending the idea of recursive partitioning. One of the representative works
is developed by Ciampi et al. (1995), who proposed tree-structure subgroup analysis using the
Recursive Partition and amalgamation (RECPAM) algorithm. Their approach is to partition patients
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into subgroups based on the similarity of their response to treatment. They considered a Cox model
λ(t|xi) = λ0(t|s, T ) exp{β · trti + γT · trti · zi}
to fit the data in the form of classification. In their model, λ0(t|s, T ) is the baseline hazard function
for the individuals in stratum s, where s is created by stratifying the terminal nodes of T . zi is a
dummy vector, function of the predictor xi, indicating the membership to one of the classes other
than the reference class. The class, or the prognosis group, is determined by γ, the log-relative
hazard with respect to the baseline, on the terminal nodes. Later, Negassa et al. (2005) investigated
the model selection in tree-structured subgroup analysis based on RECPAM and proposed a two-
stage computationally inexpensive model selection procedure.
Interaction trees (ITs), proposed by Su et al. (2008, 2009), show similar idea as Ciampi et al.
(1995). ITs recursively partition the data with censored survival times into two subsets, aiming to
obtain the greatest interaction with treatment. In other words, according to the Cox proportional
hazard model
λ(t|xi) = λ0(t) exp
{





where z(s)i is the indicator variable associated with split s, each split in ITs seeks for the greatest
interaction effect with the treatment by testing the null hypothesis of β3 = 0. Such hypothesis
can be carried out by the partial likelihood ratio test. In such a way, ITs are capable of exploring
subgroups with distinct treatment effects.
Model-based recursive partitioning algorithm (MOB) (Zeileis et al., 2008) can also be employed
for subgroup identification. MOB constructs a tree structure where each node is associated with
a single model and a fluctuation test for parameter instability is conducted to determine whether
the partitioning should be further performed. To identify subgroups in the presence of treatment-
subgroup interactions, Doove et al. (2014) states the use of MOB: one can set the model in the node
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equal to a regression model of the treatment outcome against the treatment type and the partitioning
is then applied on the baseline characteristics.
Over the past decade, more advanced methods have been well established. Dusseldorp et al.
(2010) introduced Simultaneous Threshold Interaction Modeling Algorithm (STIMA) to automat-
ically handle higher order interaction effects that can be included into a linear regression model.
STIMA simultaneously estimates a multiple regression model and a tree model, where the higher
order interaction effects can be carried out by a regression tree. According to Doove et al. (2014),
one can set the first split in the regression tree to be made on the treatment variable for the task
of subgroup identification when the interaction between treatment and subgroup is present and of
interest.
Virtual Twins (Foster et al., 2011) identifies a subgroup of patients with an enhanced treatment
effect in a randomized clinical trial. The idea, inspired by counterfactual models, consists of the
prediction of response probabilities for treatment and control ”twin” for each subject. A regression
or classification tree is applied afterwards to find a small number of covariates that have strong
association with treatment effect.
Subgroup Identification based on Differential Effect Search (SIDES) (Lipkovich et al., 2011)
discovers multiple subgroups with enhanced treatment effects based on recursive partitioning. This
method incorporates a treatment-by-split interaction in the splitting criterion and only searches
within specific regions of the covariate space to generate subgroups. SIDEScreen (Lipkovich
and Dmitrienko, 2014), the extension of SIDES, adds fixed and adaptive screens to screen out
non-informative biomarkers. The second step is to search subgroups based on selected biomarkers.
Qualitative interaction tree (QUINT) (Dusseldorp and Van Mechelen, 2014) partitions patients
into terminal nodes based on patient characteristics and the treatment responses to two alternative
treatments are evaluated subsequently. Loh et al. (2015) came up with a regression tree method to
identify subgroups with differential treatment effects. Qiu and Wang (2019) combined the estimation
of optimal piecewise linear individualized treatment rules (ITRs) and subgroup identification by
using a composite interaction tree (CITree). To achieve the simultaneous learning of optimal ITRs
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and subgroups, CITree consists of the qualitative-interaction split and the quantitative split, where
the qualitative split partitions patients into homogeneous subgroups of similar optimal ITR, and the
quantitative split is designed to reduce ITR benefit heterogeneity.
Recently, another group of methods are proposed to study heterogeneous treatment effects
using causal tree learning. The causal tree learning is leveraged by decision tree algorithm and
aims to estimate heterogeneous treatment effects based on splitting observed individuals into
groups. Athey and Imbens (2016) proposed causal trees to estimate heterogeneous causal effects in
experimental and observational studies and provided valid inference for average treatment effects for
each identified subpopulations. With the honest estimation proposed in Athey and Imbens (2016),
one sample is utilized to choose partition, and another sample is used to estimate treatment effects
for each subpopulation. Later, causal forest (Wager and Athey, 2018), extended from Breiman’s
random forest algorithm, are developed based on the work of Athey and Imbens (2016) to investigate
treatment effect heterogeneity. The analysis of bias and consistency properties for causal forest are
also discussed in their paper.
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CHAPTER 3: INFERRING LATENT HETEROGENEITY USING MANY FEATURE VARI-
ABLES WITH SURVIVAL OUTCOME
3.1 Introduction
A typical clinical trial is designed to test a drug/vaccine on a large and diverse group of patients
and hopefully the One-Size-Fits-All approach is successful. The benefit for this approach is the
quick availability of an effect drug/vaccine to the broadly targeted population with the unmet
medical need. However, with much less low-hanging fruits available, it becomes more challenging
to develop a blockbuster drug/vaccine that works for all study populations. Especially in more
advanced and hard-to-treat diseases such as oncology, patients often present a heterogeneous
survival experience, and their disease outcomes may be early death or spontaneous progression
of the tumor followed by cure. This traditional one-size-fit-all approach may not be cost and time
effective due to the high heterogeneity of the study population. As technology advances, more
personal clinical, genetic, genomic, and environmental information and other baseline characteristic
variables are available before the clinical study. Consequently, sponsors are looking into ways to
conduct study in a more homogeneous subgroup with much higher probability of success to develop
new medicines effectively. Thus, a challenging statistical problem with strong scientific/clinical
interest in drug discovery and development is the identification of patient subgroups with different
survival experience and potential treatment response heterogeneity. Recently, Liao and Liu (2019)
demonstrated that many Kaplan Meier survival curves commonly seen in oncology trials can
be reconstructed using a mixture of two or three parametric survival profiles. In other words, a
disease population can be approximately decomposed into two or three latent groups with unique
corresponding survival behavior in each latent subgroup.
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In this chapter, to predict the latent subgroup membership for future individuals and identify the
important variables that are predictive of latent subgroup membership for individuals with specific
survival profiles, we propose a method for variable selection in latent subgroup identification
with time-to-event data. More specifically, we model the survival distribution through a mixture of
Weibull distributions, where each mixture represents a latent subgroup. The latent group membership
is then modelled via a multinomial distribution that may vary with feature variables. To select
important feature variables for characterizing the latent groups, the EM algorithm is first applied to
obtain the initial maximum likelihood estimate, and then the adaptive lasso penalty is introduced
for variable selection. We show that our proposed estimator enjoys the oracle property when the
number of covariates diverges with the sample size.
The rest of this chapter is organized as follows. Section 3.2 details the proposed method for
variable selection in latent subgroup identification for individuals with specific survival profiles.
Theoretical results are provided in Section 3.3. Section 3.4 shows the finite sample performance of
our proposed method via two simulation studies. Two real data examples in Section 3.5 demonstrate
the applications of the proposed method.
3.2 Methodology
3.2.1 Model
We assume that the whole population consists of K different subgroups. Each group of patients will
follow a specific survival profile. More specifically, we assume that the kth group has a survival distribution
S(t, ηk), which has a parametric form with unknown parameters ηk, for k = 1, . . . ,K. In this paper, we
assume that the survival outcome for each latent subgroup follows a Weibull distribution, which is a commonly
used distribution in survival analysis due to its flexibility and reliability (Liao and Liu, 2019). The functional






ηk = (κk, λk)
T, κk is the shape parameter and λk is the scale parameter.
We let T denote the time to event and X denote all the baseline covariates, which the number of baseline
covariates could be large. To classify each patient into one of the survival groups using the baseline covariates
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X (X contains constant 1), we introduce a latent group membership B and assume
P (T > t|B = k,X) = S(t, ηk)
and




for k = 1, . . . ,K, where β1 = 0 and β2, . . . , βK are unknown parameters. Therefore, the latent group
membership determines which group the patient should belong to and this membership depends on the
baseline covariates through a multinomial distribution. Clearly, the proposed model implies that the marginal
survival distribution for T takes a mixture form:




where β = (βT2 , . . . , β
T
K)
T. To conduct a future trial, for any new patient with baseline covariates X = x,
we then classify this patient into group k with maximal value βTk x, i.e., the most likely group membership.
3.2.2 Initial Estimate
Suppose that we have right-censored observations from n i.i.d patients, denoted by
{Yi = Ti ∧ Ci,∆i = I(Ti ≤ Ci), Xi, i = 1, . . . , n},
where Ci is the censoring time. Assuming that the censoring time is independent of Ti given Xi, we obtain



















where θ = (ηT, βT)T, ηT = (ηT1 , . . . , η
T
K)
T, and f(t, ηk) = −S′(t, ηk).
To estimate β, we introduce B1, . . . , Bn as the latent group membership for each subject and use the
EM algorithm to compute the maximum likelihood estimators, treating the B′s as missing data. In the E-step,
at the kth iteration, we compute the expected log-likelihood based on the current estimates of all parameters,
conditional on the observed data, which is equivalent to calculating the posterior probability of Bi = k given















qik[∆i log (f(Yi, ηk))
+ (1−∆i) log (S(Yi, ηk)) + log (πk(Xi;β))]. (3.2)
To estimate the survival distribution parameter η, we implement the Newton-Raphson algorithm to update
the estimate based on the expected log-likelihood function (3.2). The expected log-likelihood function (3.2)
is essentially a weighted multinomial regression. To obtain the maximum likelihood estimate β̃, for each
iteration, we apply a one-step Newton-Raphson in the M-step to update the estimate. After convergence, we
obtain the maximum likelihood estimates η̃ and β̃. It is easy to see that the expected log-likelihood function
(3.2) in the M-step increases at each iteration, which implies that the algorithm is guaranteed to converge and
will stay unchanged once converged.
To determine the best number of latent subgroups in the data, we consider several choices of the number
of latent subgroups. For each potential number of latent subgroups, we apply a similar procedure as stated in
this section to obtain the initial estimates. The value of the log-likelihood based on the initial estimates is
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computed afterwards. The BIC, as suggested by Nylund et al. (2007), is then calculated to determine the best
number of latent subgroups for the data Nylund et al. (2007) evaluated the performance of several information
criteria for correctly identifying the number of groups. The performance of BIC for determining the best
number of latent subgroups is also evaluated in Section 3.4.
3.2.3 Variable Selection for Latent Groups
The objective function (3.2) in the M-step is essentially a weighted multinomial regression, with weights
being the posterior probability of Bi = k given the observed data for k = 1, . . . ,K and i = 1, . . . , n. We use
this objective function to accommodate penalties for variable selection. Because of the strict concavity of the
objective function (3.2), we can derive nice theoretical properties for the estimator after variable selection.
Among many penalty functions, we apply the convex adaptive lasso penalty to the objective function
(3.2). The weight for each coefficient in the adaptive lasso penalty is related to the importance of the
corresponding covariate and helps to adaptively penalize each coefficient by tuning each coefficient with a
different parameter. Zou (2006) shows that the adaptive lasso enjoys the oracle properties by inflating the
weights for zero-coefficient covariates and enables the weights of nonzero-coefficient covariates to converge
to a finite constant. The data-dependent adapting weights can be the reciprocal of any consistent estimator of
β (Zou, 2006). Here we consider the maximum likelihood estimator β̃. The penalized objective function
becomes








where γ is a prespecified positive constant and the commonly used value is γ = 1, and β = (β11, β12, . . . , β1d, β21, . . . , βKd)T .
Here, we do not introduce a penalty on η, and η̃ is the maximum likelihood estimator. Hence, minimizing
(3.3) is equivalent to applying the adaptive lasso penalty to a weighted multinomial regression.
To obtain the adaptive lasso estimates β̂, we minimize the penalized objective function (3.3) via a
two-step strategy. The first step is to calculate the maximum likelihood estimates (η̃, β̃) that optimize (3.2)
by an iterative Newton-Raphson update. Denote θ = (η, β). Define the gradient vector ∇ln(θ) = ∂ln(θ)∂θ and
the Hessian matrix∇2ln(θ) = ∂
2ln(θ)
∂θ∂θT
. The Newton-Raphson update is





The second step is to obtain the adaptive lasso estimates β̂ by minimizing (3.3) via a coordinate descent
algorithm, where the coefficients are iterated over to minimize (3.3).
Hence, to minimize the penalized objective function (3.3) for any fixed γ, we use the following procedure.
Step 1. Use the EM algorithm and the Newton-Raphson update (3.4) to compute the maximum likelihood
estimates η̃ and β̃.
Step 2. Calculate the weights in the adaptive lasso penalty, w̃i for i = 1, . . . , n, by using β̃.
Step 3. Compute the weights, qik for i = 1, 2, . . . , n, and k = 1, 2, . . . ,K, in the weighted multinomial
regression ln(η̃, β) by using η̃ and β̃.
Step 4. Apply the coordinate descent algorithm to minimize the penalized objective function (3.3) until the
convergence criterion is met.
In Step 3, the weights in the weighted multinomial regression are obtained by plugging in the estimates
η̃ and β̃, since η̃ and β̃ are consistent maximum likelihood estimates, and the weights are fairly close to the
true weights, which is shown in the Appendix. The minimization in Step 4 is based on the coordinate descent
algorithm, which can be implemented via a statistical package such as glmnet in R.
To select the data-dependent tuning parameter λ in the proposed algorithm, we use V -fold cross
validation. We consider λ from a set of grid points and partition the data into V subsets with equal size.
For each point λ, we compute the coefficients using V − 1 subsets and obtain the deviance residual on the
V th subset by using these coefficients V times. Averaging over V deviance residuals, we have an average
deviance residual associated with one point of λ. We then select among the average deviance residuals and
have the best choice for the tuning parameter λ that yields the smallest average deviance residual. After
variable selection, we reapply the EM algorithm and maximize (3.1) by including the selected important
covariates. We then classify patients to their most likely latent subgroup based on the post-selection maximum
likelihood estimates.
3.3 Theoretical Properties
In this section, we describe the asymptotic properties of our estimators when the number of param-




(βn1, . . . , βnpn)
T, where pn is the number of variables, and θn = (ηT, βTn )
T. We consider the penalized
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objective function based on n samples,








βn10 = (βn10, βn20, . . . , βnq0)
T
consists of all q nonzero components and
βn20 = (βn(q+1)0, βn(q+2)0, . . . , βnpn0)
T





We require the following regularity conditions.
(C1) The function S(t, ηk) for k = 1, 2, . . . ,K is non-increasing and continuously differentiable.
(C2) Let g(Xi, Yi,∆i, θn) Denote the probability density for observation {Xi, Yi,∆i}, for i = 1, 2, . . . , n.
The observations {Xi, Yi,∆i, i = 1, 2, . . . , n} are independent and identically distributed. Let
λmin(A) and λmax(A) denote the minimum and maximum eigenvalues of a positive definite matrix
A, respectively. Assume that, for all i, the Fisher information matrix
In(θn) = E
[(
∂ log g(Xi,Yi,∆i, θn)
∂θn
)(




C1 ≤ λmin{In(θn)} ≤ λmax{In(θn)} ≤ C2
and, for j, l = 1, 2, . . . , pn,
E
[(
∂ log g(Xi, Yi,∆i, θn)
∂η








∂ log g(Xi, Yi,∆i, θn)
∂βnj




where C1, C2, C3 and C4 are positive constants.
(C3) θn0 is contained in a large enough open set. For all θn within this open set, the third derivatives of
g(Xi, Yi,∆i, θn) with respect to βn satisfy
∣∣∣∣∂3 log g(Xi, Yi,∆i, θn)∂βnj∂βnl∂βnm
∣∣∣∣ ≤Mnjlm(Xi, Yi,∆i)
and
E[M2njlm(Xi, Yi,∆i)] ≤ C5, where C5 is a positive constant







Condition (C1) requires S(t, ηk), k = 1,2, . . . ,K to be a valid survival distribution. Conditions (C2)
and (C3) are similar to conditions (F) and (G) in Fan et al. (2004), which assume that the likelihood function
has reasonably good behavior. Condition (C4) is used to establish the oracle property of the adaptive lasso
estimator and already implicitly assumed in a finite dimensional setting. This condition is exactly condition
(H) in Fan et al. (2004), which allows nonzero coefficients to vanish and can be distinguished at a rate by the
penalized likelihood.
Under conditions (C1) - (C4), we have the following asymptotic results for our estimators.






















Theorem 3.2. If√npnλn = O(1) and p4n/n→ 0 as n→∞, then there is a unique maximizer θ̂n ofQn(θn)




Finally, we provide the asymptotic distribution of the adaptive lasso estimator. We let
bn = {0, . . . ,0, λnsign(βn10)/|β̃n1|γ , . . . , λnsign(βnq0)/|β̃nq|γ}T,
θn1 = (η
T , βTn1, 0
T )T and θn10 = (ηT0 , β
T
n10, 0
T )T . Let s be the number of parameters for the survival
distributions of the K latent subgroups. The first s zeros contained in bn are due to the fact that we do not
penalize the parameters of the survival distributions.
Theorem 3.3. If nλn → 0,
√
n/pnλn →∞ and p5n/n→ 0 as n→∞, then under Theorem 1, the adaptive
lasso estimator θ̂n has the following properties:





n (θn10){In(θn10)}[θ̂n1 − θn10 + {In(θn10)}−1bn] −→D N(0,G)
where An is a r × (s+ q) matrix such that AnATn → G, and G is a r × r non-negative symmetric matrix.
One key to the proofs is to obtain a uniform approximation rate for the weights in the expression of
Qn(θn). For this, we use the result established in Theorem 1. The proofs of Theorems 2 and 3 then follow the
standard arguments in variable selection for parametric models, including the existence of the local maximum
in a neighborhood of the true parameters and verification of the fact that the oracle estimator attains this
local maximum, but with careful verification of certain approximation rates in terms of pn. The details of
the proof are given in the Appendix. The theoretical properties for the post-selection estimator, that is, the
maximum likelihood estimator of selected important variables after refitting the model without the adaptive
lasso penalty, could be easily obtained. Under Theorem 3, the probability that adaptive lasso estimator of
unimportant variables does not equal to zero tends to 0. Therefore, the post-selection estimator has the same
asymptotic distribution as the adaptive lasso estimator of important variables, which is stated in Theorem 3.
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3.4 Simulation Studies
We conduct the simulation study that assumes two latent subgroups exist. We consider 10, 30 and
50 covariates in the regression model and only a few of covariates have nonzero effects. The covariates
X = (X1, X2, . . . , Xp), where p = 10, 30, 50, are generated from standard normal distribution with
moderate correlations. Time to event data for each latent subgroup follow a different Weibull distribution with
scale parameter λ and shape parameter κ. The censoring time is generated from an exponential distribution,
where the mean is calibrated by a prespecified censoring rate of 10%.
The true values of the scale parameters (i.e., λ1 and λ2) of the Weibull distributions for two latent
subgroups are set to be 1 and 4.5 respectively, and the true values of the shape parameters (i.e., κ1 and κ2)
are 1 and 3 for two latent subgroups respectively. Around 40% of the individuals belong to latent subgroup 1
with a 2-year survival probability of 13.5%. Sixty percent of the individuals are in latent subgroup 2 and have
a 2-year survival probability of 91.5%. The subgroup-specific survival curves are illustrated in Figure 3.1.
The true β associated with latent subgroup membership is calibrated such that the true proportions of the two
subgroups are 40% and 60%, respectively. Three scenarios in the simulation study are described below. The
sensitivity analysis that evaluates the proposed model when the link function of the multinomial distribution
for the latent subgroup membership is nonlinear is included in the Appendix.
Scenario 1. 10 covariates are independently generated from a standard normal distribution, and first





 0, 0, 0, 0, 0, . . . , 0
0.4, 0.2, −0.6, −0.3, 0, . . . , 0

Scenario 2. 30 covariates are generated from standard normal distribution, and first eight of them have






 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, . . . , 0
0.4, 0.2, −0.6, −0.3, 0.5, −0.5, 0.7, −0.7, 0.5, 0, . . . , 0

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Scenario 3. 50 covariates are generated from standard normal distribution, and first eight of them have
nonzero effects. Correlations between X1 and X2, X3 and X4, X7 and X10 are set to be 0.2, 0.3 and 0.2,
respectively. True values of regression coefficients for important variables are set to be the same as in scenario
2.





























Figure 3.1: The true survival curves in the simulation study.
To implement the EM algorithm to obtain the maximum likelihood estimators of the β’s and the survival
distribution parameters κk, λk for k = 1, 2, . . . ,K, the stopping criteria for EM is |lobs(θ(k+1))−lobs(θ(k))| <
10−4, where θ = (κ1, λ1, . . . , κk, λk, βT )T . For γ in the adaptive lasso penalty, we use γ = 1 for all
simulation studies. For each simulated dataset, we first identify the number of latent subgroups by applying
our method for estimation and calculating BIC. Once the number of latent subgroups is determined, we use the
EM algorithm to obtain the maximum likelihood estimates and then implement the adaptive lasso procedure
to perform variable selection. We consider the grid 2−16, 2−15, . . . , 215, 216 for the tuning parameter λ, and
report the results that yield the smallest value of average deviance residual. After variable selection, the EM
algorithm is reapplied to the models with only selected covariates. We repeat the simulation 1000 times and
consider sample sizes of n = 300, 1000 and 3000.
We first calculate BIC for models assuming no latent subgroups, two, and three latent subgroups, in
datasets that truly consisted of two latent subgroups. BIC suggests that approximately 100% of the datasets
with the sample size of 1000 consist of two latent groups. When the sample size increases to 3000, all the
datasets are correctly detected consisting of two latent subgroups by the BIC criterion.
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Table 3.1 summarizes the prediction accuracy, along with standard errors, for models without and after
variable selection for all three scenarios, and also reports the average number of correct and incorrect zero
coefficients and corresponding standard errors. The prediction accuracy is calculated by applying the decision
rule obtained from the training set to a validation set with sample size 10, 000. Compared to the optimal
accuracy rate, our method performs well for all three scenarios, especially for models with only selected
important covariates. The prediction accuracy is approaching to the optimal accuracy rate as the sample
size increases. When the number of covariates increases, our method also works well in terms of prediction
accuracy and variable selection results. The optimal accuracy rate is 1−Bayes error rate, where the Bayes




P (B = k|X)
)
, is the lowest possible test error rate.
For scenario 1, when the sample size is 300, important variables are correctly selected in approximately
80% of the datasets, and unimportant variables are selected in approximately 15% of the datasets. As the
sample size increases to 1000, important variables are identified in over 99% of the datasets. Meanwhile,
the ability to shrink zero coefficients to zero is also improved: the rate of incorrectly selecting unimportant
variables is below 5%. For scenario 2 when the number of covariates increases to 30, important variables
can be correctly identified in around 80% of the datasets when the sample size is 300, while the unimportant
variables are selected in around 32% of the datasets. The ability to identify important variables and shrink
zero coefficients to zero is improved when the sample size grows to 1000: important covariates can be picked
out in approximately 95% of the datasets, and our method selects unimportant variables in only 5% of the
datasets. For scenario 3 with 50 covariates, when the sample size is 300, around 80% of the datasets can
correctly distinguish important variables and the rate of incorrectly selecting unimportant variables is 35%.
As the sample size increases to 1000, the rates of identifying important variables and selecting unimportant
variables are 80% and 11%, respectively. When the sample size further grows to 3000, over 99% of the
datasets can correctly recognize important variables and the rate of incorrectly selecting unimportant variables
decreases to around 1%. Table 3.2 reports the accuracy of nonzero coefficient post-selection estimates, their
standard errors and coverage probabilities for nominal 95% confidence intervals for scenario 1. Due to
the limited space, we report results for scenario 2 and 3 in the Appendix. To obtain the standard errors
for the maximum likelihood estimates, we use the Louis formula (Louis, 1982) because the latent group
membership is treated as missing data in our method. For these three scenarios, we observe similar results:
the post-selection estimates are slightly biased on small samples and the bias can be reduced by increasing the
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sample size; the 95% confidence intervals for the post-selection estimators based on the estimated coefficients
and standard errors have accurate coverage for the true parameters.
Table 3.1: Results from the simulation study with 2 latent groups
Accuracy (SE) Comparison
without after Group 2 vs. 1
N variable selection variable selection Corr. (SE) Incorr. (SE)
Scenario 1: 10 independent covariates, 3 of them are important.
The optimal accuracy rate is 0.648.
300 0.617 (0.019) 0.619 (0.030) 5.70 (1.754) 0.63 (0.876)
1000 0.636 (0.009) 0.640 (0.010) 6.53 (0.946) 0.08 (0.278)
3000 0.643 (0.006) 0.645 (0.015) 6.90 (0.326) 0.00 (0.045)
Scenario 2: 30 covariates with moderate correlations, 8 of them are important.
The optimal accuracy rate is 0.732.
300 0.675 (0.020) 0.680 (0.029) 13.47 (6.574) 0.86 (1.146)
1000 0.716 (0.007) 0.724 (0.008) 19.71 (3.245) 0.24 (0.459)
3000 0.728 (0.005) 0.731 (0.005) 21.41 (1.256) 0.03 (0.159)
Scenario 3: 50 covariates with moderate correlations, 8 of them are important.
The optimal accuracy rate is 0.732.
300 0.653 (0.019) 0.666 (0.030) 27.39 (10.290) 0.84 (1.178)
1000 0.705 (0.008) 0.720 (0.010) 36.45 (6.969) 0.22 (0.430)
3000 0.724 (0.005) 0.731 (0.005) 40.86 (2.783) 0.03 (0.179)
Note. Each column corresponds to prediction accuracy and standard errors, average number of
correct (Corr.) and incorrect (Incorr.) zero coefficients and standard errors from 1000 simulated
datasets.
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Table 3.2: Maximum likelihood Estimates after variable selection, their standard errors, and coverage
probabilities for nominal 95% confidence intervals from the simulation study with 2 latent groups
N Parameter Bias SE SEE CP
300 k1 0.035 0.113 0.109 0.954
λ1 0.015 0.274 0.254 0.852
k2 0.096 0.422 0.354 0.915
λ2 -0.013 0.210 0.190 0.902
β0 -0.003 0.350 0.318 0.901
β1 -0.033 0.186 0.110 0.605
β2 -0.002 0.277 0.172 0.866
β3 0.005 0.202 0.145 0.807
1000 k1 0.013 0.062 0.061 0.946
λ1 -0.000 0.166 0.160 0.890
k2 0.007 0.203 0.190 0.931
λ2 -0.015 0.109 0.109 0.940
β0 0.010 0.195 0.187 0.916
β1 -0.008 0.101 0.080 0.883
β2 -0.017 0.101 0.097 0.949
β3 -0.006 0.088 0.089 0.962
3000 k1 0.004 0.036 0.036 0.942
λ1 0.002 0.099 0.099 0.925
k2 0.006 0.110 0.111 0.952
λ2 -0.003 0.065 0.064 0.949
β0 0.002 0.111 0.112 0.939
β1 0.000 0.049 0.050 0.954
β2 -0.007 0.056 0.055 0.948
β3 -0.005 0.051 0.051 0.947
Note: SE, standard error; SEE, mean of standard error estimator; CP, coverage probability for
nominal 95% confidence interval.
3.5 Real Data Application
3.5.1 Application to IBCSG Data
We apply the proposed methodology to data from a breast cancer clinical trial to study the potential
heterogeneity of patients in terms of their survival outcomes and investigate important variables that are
associated with such heterogeneity. The data was collected from a large clinical trial, IBCSG Trial VI
(Colleoni et al., 2002), in premenopausal women with node-positive breast cancer to study both the duration
of adjuvant chemotherapy and the reintroduction of delayed chemotherapy. Patients were randomized in a
two by two factorial design to receive the following: (A) cyclophosphamide, methotrexate, and fluorouracil
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(CMF) for six consecutive cycles (CMF*6); (B) CMF*6 plus three single cycles of reintroduction CMF;
(C) CMF*3; and (D) CMF*3 plus three single cycles of reintroduction CMF. The patients’ quality of life
(QOL) was also measured at baseline and was hypothesized to contain prognostic information and reflect
breast cancer progression. Four aspects of QOL, including physical well-being, mood, appetite and perceived
coping, were assessed by a self-assessment QOL questionnaire. In addition to treatment effects and patients’
QOL, disease-free survival (median follow-up of 7.47 years, rescaled to [0, 1]), event status, age at baseline,
estrogen receptor (ER) status (1=positive, 0=negative) and the number of positive nodes of the tumor (i.e.,
node group, 1=number of positive nodes > 4, 0=else) are also considered in the data. After excluding missing
values, data are available for 962 patients. The median follow-up for disease free survival (DFS) is 7.47 years
and the event rate is around 45%. We rescale the DFS to [0, 1] and standardize continuous variables such as
age and the four measures of QOL for computation.
The results of variable selection indicate that treatment does not have a significant effect on the latent
subgroup membership assignment. To further explore the heterogeneity of patients under different therapeutic
procedures, we apply our method to the datasets of patients under each treatment. According to BIC, two
latent subgroups are detected among patients with treatment B and patients with treatment C, and no latent
subgroup is identified among patients with treatment A and treatment D. More specifically, for treatment A,
the BICs for models assuming no latent subgroup, two and three latent subgroups are calculated as 257.5,
311.7 and 382.4 respectively. For treatment B, the BICs for these three models are 258.2, 221.0 and 347.2
respectively. For treatment C, BICs for these three models become 225.0, 203.9 and 260.0 respectively. For
treatment D, the corresponding BIC values for these three models are 250.0, 278.4 and 305.1. Table 3.3
reports the estimated regression coefficients for patients under treatment B and patients under treatment
C. Assuming that the survival outcomes for patients follow a Weibull distribution, among patients under
treatment B, the survival distribution estimates yield a shape parameter of 3.06 and a scale parameter of 0.24
for latent group 1, and a shape parameter of 1.88 and a scale parameter of 1.44 for latent group 2, based on
the model without variable selection. For patients under treatment C, the survival distribution estimates yield
a shape parameter of 2.57 and a scale parameter of 0.28 for latent group 1, and a shape parameter of 2.21 and
a scale parameter of 1.74 for latent group 2, based on the model without variable selection. After variable
selection, two estimated Weibull distributions yield κ̂1 = 2.88, λ̂1 = 0.27, κ̂2 = 1.87 and λ̂2 = 1.84 for
patients under treatment B, and κ̂1 = 2.57, λ̂1 = 0.28, κ̂2 = 2.10 and λ̂2 = 1.75 for patients under treatment
28
C. The middle and right panels of Figure 3.2 demonstrate survival profiles for two latent groups from patients
under treatment B and treatment C. After we obtain the predicted latent group membership, A logrank test
is performed to evaluate the difference between survival profiles for two latent groups from patients under
treatment B and treatment C. P-values from logrank test are smaller than 0.0001, which implies that, among
patients under treatment B and treatment C, two latent groups are significantly different in terms of their
survival profiles.
Based on the results of variable selection, we find that for patients under treatment B, the latent subgroup
membership assignment is associated with age, the number of positive nodes, ER status, physical well-being
and mood. When looking at patients under treatment C, only age and the number of positive nodes are
predictive of the latent subgroup membership assignment, which agrees with the findings in the overall model.
With these findings, we conclude that some latent subgroups of patients under treatment B and treatment C
respond to the treatment differently due to some important covariates such as age and the number of positive
nodes. Therefore, it is of interest to further study how the treatment works differently for some subgroups
that are determined by important covariates. We create four subgroups of patients based on dichotomized age
and the number of positive nodes. More explicitly, we dichotomize age by a threshold of 40 years, which is
learned from previous findings about the IBCSG trial (International Breast Cancer Study Group, 1996). A Cox
proportional hazards model with treatment as the only covariate is then applied to each subgroups of patients
to evaluate the treatment effect. In the subgroups of patients aged less than 40 years and with more than 4
positive nodes, treatment C has a significant effect on the survival outcomes (p-value=0.031). Compared
with treatment A, the hazard ratio of treatment C is 2.48 with 95% confidence interval (1.085, 5.666), which
implies that the hazard for patients treated with CMF*3 is higher than for patients treated with CMF*6.
Kaplan-Meier curves for patients under each treatment in different subgroups are demonstrated in Figure 3.3.
3.5.2 Application to Assay of Free Light Chain Data
Our proposed method is also applied to the assay of free light chain data, which involves a study of the
relationship between the assay of free light chain (FLC) and mortality. The serum FLC assay is important in
the diagnosis, prognosis, and disease measurement of plasma cell disorders, such as monoclonal gammopathy
of undertermined significance (MGUS), multiple myeloma, and amyloidosis. Dispenzieri et al. (2012) found
that elevated FLC levels were indeed associated with higher death rates in the general population.
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Note: “Time” is disease free survival and rescaled to [0, 1].
Figure 3.2: Kaplan-Meier Curves for latent subgroups and for subgroups determined by age and the
number of positive nodes
The data of assay of serum free light chain consist of an age and sex stratified random sample of residents
of Olmsted County aged 50 or older. Our analysis involves 6521 individuals after excluding those with
missing values. Events were observed in 1959 individuals, with an event rate of 30% and a median follow-up
time of 11.8 years. We first determine that two latent subgroups exist in the data, which is suggested by a
BIC of value 5340.8 based on the model assuming two latent subgroups in the data. BIC of models assuming
no latent subgroup and three latent subgroups in the data are 7273.2 and 5719.3, respectively. Next, we
apply the EM algorithm to estimate the survival distributions, assuming that the underlying survival follows a
Weibull distribution. The estimated shape parameters of the Weibull distribution for two latent groups are
1.09 and 1.39, respectively. The corresponding scale parameter estimates are 0.54 and 4.50. The coefficients
estimates for the baseline covariates are reported in Table 3.4. Under this model, we implement our variable
selection procedure to select important covariates that are associated with latent subgroup membership
assignment. After variable selection, we refit the model using the selected nonzero covariates. The estimated
Weibull distributions for two latent subgroups are very close to those without variable selection: the survival
distribution for latent group 1 has a shape parameter estimate of 1.08 and scale parameter estimate of 0.54; the
survival distribution for latent group 2 has a shape parameter estimate of 1.38 and scale parameter estimate of
4.46. The results of the adaptive lasso estimator and maximum likelihood estimator after variable selection
are summarized in Table 3.4.
The latent subgroups membership is associated with the main effects of age, sex, log of the kappa portion
of serum free light chain, log of lambda portion of serum free light chain and log of serum creatinine, and
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Table 3.3: Parameter estimates for the IBCSG trial data
Overall models Treatment-specific models
Treatment B Treatment C
MLE w/o MLE after MLE w/o MLE after MLE w/o MLE after
Covariates var. sel. var. sel. var. sel. var. sel. var. sel. var. sel.
(p-value) (p-value) (p-value) (p-value) (p-value) (p-value)
(intercept) 1.21 1.21 1.09 1.05 0.90 0.87
(<0.0001) (<0.0001) (0.0017) (0.0019) (0.0176) (0.0009)
age 0.25 0.25 0.16 0.16 0.57 0.55
(0.0034) (0.0030) (0.3316) (0.3309) (0.0015) (0.0017)
node -1.06 -1.05 -1.74 -1.77 -1.26 -1.16
(<0.0001) (<0.0001) (<0.0001) (0.0033) (0.0007) (0.0011)
ER status 0.13 0 0.32 0.32 0.03 0
(0.4869) (-) (0.3811) (0.3740) (0.9277) (-)
physical 0.08 0 -0.17 -0.08 0.22 0
(0.4456) (-) (0.4591) (0.7095) (0.2959) (-)
mood -0.24 0 -0.02 -0.42 -0.36 0
(0.0375) (-) (0.0129) (0.0451) (0.1271) (-)
appetite 0.04 0 0.26 0 0.02 0
(0.6430) (-) (0.2178) (-) (0.8964) (-)
cope 0.21 0 0.27 0 0.32 0
(0.0302) (-) (0.2008) (-) (0.0953) (-)
trtB -0.03 0 - - - -
(0.8884) (-) (-) (-) (-) (-)
trtC -0.17 0 - - - -
(0.4925) (-) (-) (-) (-) (-)
trtD -0.08 0 - - - -
(0.7354) (-) (-) (-) (-) (-)
Note. “node”: the number of positive nodes in the tumor; “physical”: physical well-being; “cope”:
perceived coping.
interaction effects of age and sex, age and log of lambda portion of serum free light chain, sex and log of
lambda portion of serum free light chain, sex and log of serum creatinine, and log of kappa portion of serum
free light chain and log of serum creatinine. The latent subgroup membership for each individual is predicted
afterwards, based on maximum likelihood estimates without variable selection and after variable selection.
The model without variable selection yields that 1693 out of 6521 individuals belong to latent group 1, which
makes up about 26% of the total individuals in the data. After variable selection, 1701 individuals (≈ 26.1%)
belong to latent group 1. Kaplan-Meier curves for two latent subgroups are utilized to illustrate the survival
profiles, which are shown in Figure 3.4.
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Table 3.4: Parameter estimates for the assay of free light chain data
Covariates MLE without MLE after
variable selection (p-value) variable selection (p-value)
(intercept) 2.16 (0.4188) 2.60 (<0.0001)
age -3.16 (<0.0001) -3.37 (<0.0001)
sex 1.54 (0.0001) 1.19 (0.0011)
kappa -0.83 (0.6086) -0.75 (0.0009)
lambda -1.98 (0.4480) -1.50 (0.0001)
creatinine 2.62 (0.0083) 0.49 (0.4900)
age sex -0.26 (0.3669) -0.04 (0.8880)
kappa lambda sum 0.79 (0.8487) 0 (-)
kappa lambda ratio -0.40 (0.2036) 0 (-)
kappa age 0.36 (0.3745) 0 (-)
kappa sex -0.50 (0.3369) 0 (-)
lambda age 0.98 (0.0240) 1.25 (0.0001)
lambda sex -0.60 (0.3301) -0.64 (0.1173)
creatinine age -0.96 (0.1890) 0 (-)
creatinine sex 1.05 (0.1534) 0.61 (0.4336)
kappa creatinine -0.30 (0.7889) -2.18 (0.0019)
lambda creatinine -3.43 (0.0090) 0 (-)
Note: “Age” is in years, standardized by subtracting mean and dividing standard deviation. “kappa”’
is the log of kappa portion of serum free light chain. “lambda” is the log of lambda portion of
serum free light chain. “creatinine”’ is the log of serum creatinine. “age sex”’ is the interaction of
standardized age and sex. “kappa lambda sum”’ is the log of sum of kappa and lambda free light
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Note: Top-left panel: subgroup of patients with age less than 40 years old and the number of positive
nodes less than 4. Top-right panel: subgroup of patients with age more than 40 years old and the
number of positive nodes less than 4. Bottom-left panel: subgroup of patients with age less than 40
years old and the number of positive nodes more than 4. Bottom-right panel: subgroup of patients
with age more than 40 years old and the number of positive nodes more than 4. Treatment A is the
reference for hazard ratio and corresponding confidence interval estimates. P-value corresponds to
the logrank test of treatment effect for each subgroup. “Time” is disease free survival and rescaled
to [0, 1].
Figure 3.3: Kaplan-Meier Curves for patients under each treatment in different subgroups
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Note: “Time” is the time from enrollment until death and rescaled to [0, 1].
Figure 3.4: Kaplan-Meier Curves for two subgroups for the assay of free light chain data, based on
MLE estimates after variable selection
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3.6 Conclusion
In this chapter, we propose a novel algorithm to detect the latent subgroups for individuals with different
survival profiles and identify important covariates that are associated with the latent subgroup membership
assignment. We have shown that our proposed estimator is consistent and enjoys the oracle properties when
the number of covariates diverges with the sample size. Our proposed method can simultaneously estimate
the unknown survival distributions and the coefficients that are predictive of latent subgroup membership
assignment. The data with a large number of covariates can be handled well through a penalized objective
function. This proposed methodology would potentially work as an exploratory step in clinical trial settings
before implementing a subgroup analysis to study the treatment effect. The selected important covariates
may help to explicitly determine the subgroup and discover how patients in different subgroups respond
differently to treatments. Specific treatments could be developed for a target group of patients subsequently.
Furthermore, using this proposed algorithm, we could directly classify patients into high-risk and low-risk
groups based on their survival profiles. Since the identified classes have distinct survival distributions, each
class is clinically meaningful, corresponding to patients with either long or short survival trajectories. Thus,
the obtained classes can be useful to differentiate subgroup of patients at least in the following direction. First,
the obtained latent classes can be used for patient recruitment in conducting future clinical trials. For example,
we can recruit more patients from the high-risk group to empower trials. Another potential application is as
illustrated in the real data application, our method can be used to identify subgroups of patients who may
more benefit from one treatment as compared to the rest and to explore the baseline characteristics of these
subgroups of patients, or their intersections, based on selected important covariates.
In our proposed algorithm, the survival distributions for latent subgroups are assumed to follow Weibull
distributions with unknown parameters. It is easy to extend out methodology to other parametric distributions,
such as the exponential distribution and the lognormal distribution. Our parametric framework could also be
weakened by assuming that the baseline hazard function is semi-parametric and we estimate the baseline
cumulative hazard function using the Breslow’s estimator.
The distribution of the latent subgroup membership, given baseline covariates, is assumed to be a
multinomial distribution. This assumption could be relaxed by considering a tree-based partition on the data,
which could be used to identify latent subgroups and select important covariates in a nonparametric framework.
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The tree-based method for latent subgroup identification may be helpful for handling the data with many
covariates. Lastly, the way we select the best number of latent subgroups is to essentially apply the proposed
method to the data by assuming a different number of latent subgroups in the data. A nonparametric approach
for determining the best number of latent subgroups could be established as well. We could implement the
tree-based partition procedure based on several choices of the number of latent subgroups assumed in the data,
compute BIC values for each choice and select the number of latent subgroups associated with the smallest
value of BIC. Semi-parametric approaches and their theoretical justification will be detailedly discussed in
Chapter 4.
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CHAPTER 4: MIXTURE SURVIVAL TREES FOR CANCER RISK CLASSIFICATION
4.1 Introduction
In oncology studies, identifying subpopulations who are high-risk or vulnerable for cancer relapse or
death is crucial for drug development, due to extensive heterogeneity among cancer patients and the great
cost for conducting oncology studies. Accurate risk classification, which evaluates an individual patient’s
survival based on his/her clinical status, genetic markers, and environmental exposure, is also essential for
developing targeted cancer therapies in the era of precision medicine.
Parametric or semiparametric survival models are commonly used to evaluate individual risks. For
example, one can fit a Cox proportional hazards model (Cox, 1972) or other transformation models (Zeng
et al., 2016) to obtain a risk score as a linear function of individual covariates. One example of such a
risk score is derived from the Framingham Heart Study. The analysis (Kannel and McGee, 1979; Kannel
et al., 1979; Wilson et al., 1998) revealed that coronary heart disease risk is associated with age, diabetes,
blood pressure, cholesterol level and smoking status. Another example is related to advanced oral cancer,
in which (Tseng et al., 2020) classified patients into high- and low-risk groups based on comprehensive
clinicopathologic and genetic data by using a Cox proportional hazards model and pre-specified thresholds
for risk stratification.
Nonparametric and machine learning methods have also been developed to evaluate a patient’s risk.
Decision trees, due to their simplicity and interpretability, have become a popular approach to tackle time-to-
event data in the literature. Specifically, survival trees (Ciampi et al., 1981; Marubini et al., 1983; Gordon
and Olshen, 1985) were developed to extend existing tree-based methods for continuous outcomes to handle
survival data, where splitting rules were constructed to optimize the within-node homogeneity and the
between-node heterogeneity. More recently, various splitting criteria have been greatly discussed, such as
the likelihood ratio test (Ciampi et al., 1987), exponential log-likelihood loss (Davis and Anderson, 1989),
the full likelihood deviance (LeBlanc and Crowley, 1992), the integrated absolute difference between two
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children nodes survival functions (Moradian et al., 2017), and the integrated concordance measure to evaluate
the difference in hazards of two child nodes (Sun et al., 2019). To classify patients into different risk groups,
survival functions (Ibrahim and Kudus, 2009; Zhou and McArdle, 2015) or hazard functions (Vergara et al.,
2018) at each terminal node were obtained and compared with a pre-specified threshold value to determine
the high- or low-risk group of each patient.
There are several limitations with both semiparametric and machine learning approaches for survival risk
classification. First, parametric or semiparametric models aim to study the association between the covariates
and the outcome, and therefore are not actually developed for risk classification. Model misspecification, for
example, due to the monotonicity of the risk scores from a Cox model, can lead to serious misclassification
of risk groups. Second, although machine learning methods such as survival trees are more robust to model
misspecification, they are designed for survival prediction but not for risk classification directly. In addition,
node splitting during the recursive partition is often based on comparing survival functions from nested nodes
in order to yield many distinct survival functions at terminal nodes, thus making the choice of decision for
risk classification difficult. Instead, these approaches have to rely on some crude summary statistics for the
survival functions, such as median survival or survival probabilities at given time points, to classify patients,
which likely miss the entire picture of individual survival profiles. Finally, all these methods rely on choosing
threshold values for classification, which can be subjective and may not be clinically meaningful.
Instead, a more direct approach for risk classification is to treat risk group labels for patients as missing
data so that the observed data can be used to infer these labels. For example, (Liao and Liu, 2019) pointed out
that, for some particular cancers such as melanoma, the patient population can be approximately decomposed
into two or three latent groups with unique survival profiles in each latent subgroup. Therefore, one could
consider a mixture of multiple survival distributions with unknown parameters to characterize survival profiles
for each latent group of patients. The resulting estimates for group membership, which are a parametric
function of the covariates, directly provide risk classification for each individual. Finite mixture models have
been widely used to study heterogeneity in survival data (Larson and Dinse, 1985; Farewell, 1982). Shen and
He (2015) constructed a structured logistic-normal mixture model to identify a subgroup with an enhanced
treatment effect. They further performed a confirmatory statistical test before model building to examine the
existence of subgroups. A Quasi-Newton EM algorithm (Bussy et al., 2019) explored patient risk groups based
on discrete survival data. However, all these methods are parametric that assume a restrictive relationship
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between the covariates and risk classes, and thus suffer from model misspecification. Computation is also
challenging when a large number of covariates are involved.
In this chapter, we propose a mixture survival tree method for risk classification. Specifically, we assume
that the patients can be classified into a pre-specified number of risk groups, in which each group has distinct
survival profiles that are modelled using a general family of Weibull distributions. We model each group
membership nonparametrically in terms of patient’s covariates. For estimation, we adopt tree-based methods
to estimate the group membership during an EM algorithm. At each iteration, the observed log-likelihood
function is used as the splitting criterion to optimize the within-node homogeneity and the between-node
heterogeneity in terms of patients’ survival behaviors. Since only a binary split is used at the iteration,
computation is fast and we show that the likelihood function increases over iterations. More importantly, our
proposed method provides a direct risk classification for future patients since the risk group membership can
be derived explicitly using the estimated trees.
The rest of this chapter is organized as follows. The rest of this paper is organized as follows. Section
4.2 states the motivation of the proposed tree-based method for survival risk group discovery. Section 4.3
provides details about the proposed tree-based method. Section 4.4 demonstrates the performance of the
proposed method via extensive simulation studies. The real data application is illustrated in Section 4.5.
4.2 The IBCSG Breast Cancer Trial
The development of the proposed mixture survival tree was motivated by a large clinical trial, IBCSG
Trial VI, conducted by the International Breast Cancer Study Group (IBCSG). IBCSG Trial VI studied both the
duration of adjuvant chemotherapy and the reintroduction of delayed chemotherapy in premenopausal women
with node-positive breast cancer (Colleoni et al., 2002; Chi and Ibrahim, 2006). Patients were randomized in
a two by two factorial design to receive the following: (A) cyclophosphamide, methotrexate, and fluorouracil
(CMF) for six consecutive cycles (CMF*6); (B) CMF*6 plus three single cycles of reintroduction CMF;
(C) CMF for three consecutive cycles (CMF*3); and (D) CMF*3 plus three single cycles of reintroduction
CMF. The patients’ quality of life (QOL) was also measured at baseline and was hypothesized to contain
prognostic information and reflect breast cancer progression. Four aspects of QOL, including physical
well-being, mood, appetite and perceived coping, were assessed by a self-assessment QOL questionnaire. In
39
addition to treatment effects and patients’ QOL at baseline, disease-free survival (median follow-up of 7.47
years, rescaled to [0, 1] in analysis), event status, age at baseline, estrogen receptor (ER) status (1=positive,
0=negative) and the number of positive nodes of the tumor (i.e., node group, 1=number of positive nodes > 4,
0=else) are also considered. After excluding missing values, data are available for 962 patients. The event
rate is around 45%. More details about the trial are described by International Breast Cancer Study Group
(1996).
To explore the heterogeneity of patients, Kaplan-Meier curves of disease-free survival according to
treatment for patients less than 40 years of age and for patients 40 years of age or older are used to demonstrate
the difference in patients’ survival profiles. The cut-off value of age at 40 years is learned from Colleoni
et al. (2002) which presented an increased risk of relapse for patients who were less than 40 years old on
treatment C versus treatment A. Figure 4.5 shows that patients who were less than 40 years of age respond
to different treatments differently. For example, for patients with age less than 40 years, survival curves
for those receiving treatments B and C level off after 6 years but such phenomenon is not observed for
patients receiving treatments A and D. Moreover, within the treatment group, the shapes of survival curves
are different between patients who were less than 40 years of age and patients 40 years of age or older. For
treatments A and B, survival curves for patients under different age groups cross over, while for treatments C
and D, patients younger than 40 years of age have a higher survival risk compared with patients 40 years
of age or older. These findings imply that latent heterogeneity in patients with respect to treatment exists.
Since other baseline patient characteristics are also contained in the data set, to explore how the baseline
covariates determine the latent heterogeneity in patients, we propose a tree-based method to discover latent
heterogeneity for patients with different survival profiles and directly classify patients into different survival
risk groups.
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Figure 4.5: Kaplan-Meier curves of disease-free survival according to treatment for patients less
than 40 years of age and for paitents 40 years of age or older
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Note: The top left panel illustrates the Kaplan-Meier curves for patients receiving treatment A.
Top right panel are for patients receiving treatment B. Bottom Left panel are for patients receiving
treatment C. Bottom right panel are for patients receiving treatment D.
4.3 Methodology
4.3.1 Mixture Survival Model
We assume that the entire population consists of K different survival risk groups. Each group of
patients will follow a specific survival profile. More specifically, we assume that the kth group has survival
distribution S(t,ηk), which has a parametric form with unknown parameters ηk, for k = 1, . . . ,K. In
this paper, we assume that the survival outcome for each latent risk group follows a Weibull distribution,
which is a commonly used distribution in survival analysis due to its flexibility and reliability (Liao and Liu,
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ηk = (κk, λk)
T , κk is the shape parameter and λk is the scale parameter.
Let T denote the time to event and X denotes all the baseline covariates, which could be high-dimensional.
To classify each patient into one of the survival groups using the baseline covariates X, we introduce a latent
group membership B and assume that
P (T > t|B = k,X) = S(t,ηk)
and
P (B = k|X) = exp{hk(X)}∑K
k=1 exp{hk(X)}
= gk(X),
for k = 1, . . . ,K, where hk(X) is a nonparametric function and h1(X) = 0 (we set subgroup 1 as the
reference group). Therefore, the latent group membership determines which group the patient should belong
to. This membership depends on the baseline covariates through a nonparametric distribution. Clearly, the
proposed model implies that the marginal survival distribution for T takes a mixture form:




and the probability of a patient belonging to risk group k given his or her baseline characteristics, gk(X), is
the risk score that we use to assign latent survival risk group membership. To conduct a future trial for any
new patient with baseline covariates X = x, we then classify this patient into risk group k with maximal
value gk(X), i.e., the most likely group membership.
4.3.2 Tree-based Algorithm for Model Fitting
We propose a tree-based algorithm to estimate the group classification function, gk(x), k = 1, ...,K.
Unlike traditional classification trees where the class labels are available, in our proposed tree-based method,
the label of survival risk group, B, is unknown in the data. Hence, we will treat it as missing data and the
EM algorithm will be used to address the latency of risk group membership. The basic idea of our proposed
algorithm is that the covariate space is recursively partitioned to optimize the observed data log-likelihood
function and the same survival risk group membership is assigned to patients in the same subregion of the
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covariate space. The recursive partitioning is stopped when only a few patients are included in the child
nodes.
More specifically, suppose that there are K subgroups contained in the data. We have right-censored
observations from n i.i.d. patients, denoted by
{Yi = Ti ∧ Ci,∆i = I(Ti ≤ Ci),Xi, i = 1, . . . , n},
where Ci is the censoring time. Assuming that the censoring time is independent of Ti given Xi, the observed
data log-likelihood function is given by
















and the complete data log-likelihood function is given by





I(Bi = k) [∆i log {f(Yi;ηk)gk(Xi)}
+(1−∆i) log {S(Yi;ηk)gk(Xi)}] ,
where η = (η1, . . . ,ηK)
T , f(t,ηk) = −S
′




To implement the numerical algorithm for studying the nonparametric function gk(X) and to grow a
decision tree, we first set the starting values for ηk and hk(X), for k = 1, . . . ,K. ηk’s are chosen to be close
to 0 but have different values to make sure the survival distribution for each subgroup identifiable. hk(X)
relies on the coefficients of a weighted multinomial regression model where more details will be covered
later in this section. The starting values for the coefficients of the weighted multinomial regression model are
chosen to be 0. For each splitting, based on the data Bt+1 in the current node, we apply the EM algorithm. In
the E-step, the expected log-likelihood based on all parameters conditional on the observed data is calculated,






























for i ∈ Bt+1 and k = 1, . . . ,K by using {η̂(t), h(t)2 , . . . , h
(t)
K } obtained from parent node. In the M-step, for
each feature Xj , j = 1, . . . , p, and for each potential split x, we optimize the objective function







ik [∆i log (f(Yi,ηk))
+(1−∆i) log (S(Yi;ηk)) + log (gk(Xij))]
which is equivalent to fitting a weighted multinomial regression model









exp{θ0k + θ1kI(Xij < xj)}∑K
k=1 exp{θ0k + θ1kI(Xij < xj)}
}
(4.5)
based on the current data Bt+1. To fit the weighted multinomial regression model (4.5), we use the one-step
Newton-Raphson update. More specifically, θ(t+1)0k and θ
(t+1)



























for k = 1, . . . ,K.
Next step is to search for the splitting variable and corresponding splitting value among the grid
points that optimize the observed data log-likelihood. An exhaustive search is performed on the features
Xj , j = 1, . . . , p and their corresponding potential splitting values x. Here, x can be the 20th, 30th, . . . , 80th
percentile of Xj to find the splitter {Xj′ , xj′} that maximizes the objective function (4.5). We then calculate
the corresponding {θ′0k, θ
′
1k} and update h
(t+1)
k (Xi) at each iteration by multiplying a linear combination of
an indicator function using {θ′0k, θ
′
1k} and the split {Xj′ , xj′},
h
(t+1)








1kI(Xij′ < xj′ )
}
.
The nonparametric function hk(·), k = 1, . . . ,K, demonstrates the how the covariate space is partitioned
over iterations. To estimate the survival distribution for each risk group, we consider the whole dataset B. That
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is, for each level of the tree, we combine all the data points in each of the child nodes. The Newton-Raphson
algorithm is then used to update the unknown survival parameter ηk, k = 1, . . . ,K, by computing the first
and second derivatives of the objective function







ik [∆i log (f(Yi,ηk))
+(1−∆i) log (S(Yi;ηk)) + log (gk(Xi))]
with respect to η to obtain η̂(t+1). More specifically, at each level, we only iterate once to update survival
parameters ηk, k = 1, . . . ,K, based on the whole dataset. The binary splitting is stopped when each
leaf contains no more than
√
n patients and the pruning procedure is performed backwards to obtain the
optimal-size subtree.
After fully growing a tree, we obtain the optimal-size subtree by calculating BIC for a series of subtrees.
The BIC criterion can be computed by
BIC = −2 log(L̂ik) + log(n)(l + 2K),
where log(L̂ik) is the observed data log-likelihood of the current tree, n is the number of observations in
B, and l is the number of leaves of the current tree. Pruning is stopped when the tree corresponding to the
smallest BIC is found.
A similar procedure is used to select the number of latent risk groups contained in the data by assuming
that a multiple number of latent groups exists in the data. The tree that yields the smallest BIC is then chosen
as best. We mention here that BIC penalizes the number of leaves for tree pruning, while the penalty for the
number of levels is used for the BIC calculation to select the best number of latent groups. Such a choice of
penalty for the BIC calculation is evaluated in the simulation studies in Section 4.4.
4.3.3 Monotone Likelihood Property of the Algorithm
In this section, we show that the observed data log-likelihood increases monotonically over iterations
based on the algorithm stated in Section 4.3.2.
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Without loss of generality, we pick an arbitrary node,N (t), in tth iteration and the dataset that corresponds
to this node is denoted by B(t). Assume that in the (t + 1)th iteration, two datasets, B(t+1)1 and B
(t+1)
2 ,
are obtained based on binary splitting from B(t), where B(t) = B(t+1)1 ∪ B
(t+1)
2 . With a slight abuse
of notation, we write the observed data as Yobs = {Yi,∆i,Xi, i = 1, 2, . . . , n}, the complete data as
Yc = {Yi,∆i,Xi, Bi, i = 1, 2, . . . , n}, where Bi is the latent group membership for patient i, and the
missing data as Ymis = {Bi, i = 1, 2, . . . , n}. We are led to the following theorem.
Theorem 4.4. For any node in the tth iteration and its corresponding child nodes in the (t+ 1)th iteration,
the value of the observed data log-likelihood increases between two successive iterations. That is,
l(η(t), h
(t)
2 , . . . , h
(t)
K ;Yobs ∈ B
(t)) ≤ l(η(t+1), h(t+1)2 , . . . , h
(t+1)





2 , . . . , h
(t+1)
K ;Yobs ∈ B
(t+1)
2 ),
where l(η(t), h(t)2 , . . . , h
(t)
K ;Yobs ∈ B(t)) denotes the observed data log-likelihood in the tth iteration and
l(η(t+1), h
(t+1)
2 , . . . , h
(t+1)





2 , . . . , h
(t+1)
K ;Yobs ∈ B
(t+1)
2 ) denote the ob-
served data log-likelihood in the two corresponding child nodes.
The proof of Theorem 1 is given in the Appendix.
4.4 Simulation Studies
4.4.1 Simulation Setting
We performed extensive simulation studies to evaluate the performance of our proposed tree-based
method. We consider two latent risk groups in the first simulation study and assume that the data contain
three latent risk groups in the second simulation study. In each simulation study, three different scenarios
are evaluated and the results are compared with the parametric mixture model, Cox PH model with risk
stratification and survival tree. We apply the parametric mixture model by following Bussy et al. (2019). A
mixture form, f(t|X = x) =
∑K
k=1 πk(x)fk(t;αk), is considered to model the conditional probability of
the survival time T given the baseline covariates. The weights, πk(x), for each mixing component depend




EM algorithm is used to handle the latency of the survival risk group label. The regression coefficients of
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the covariates are estimated by the Newton-Raphson algorithm and then are used to classify patients into
different survival risk groups. Note that this approach can be applied to any parametric distribution. The Cox
PH model with risk stratification is an application of Tseng et al. (2020), where a Cox PH model including all
covariates is applied to the training set and the threshold for survival risk group classification is set to be the
median survival times of the training set (tertiles of survival times in observed samples are used for three
latent groups scenarios). This threshold will be used to dichotomize the survival data in the test set and the
survival risk groups are obtained accordingly. The survival tree is implemented using the R package, rpart,
where a survival tree that includes all covariates is fitted on the training set and the median survival times of
the training set (tertiles of survival times are used for three latent groups scenarios) are set to be the threshold
for survival risk group classification. The survival risk groups are obtained by dichotomizing the survival
data in the test set using the threshold. We will not incorporate any variable selection procedures to compare
the different methods.
For the simulation of two latent subgroups, ten baseline covariates, X1, X2, . . . , X10, are considered in
the model and only a few of them have nonzero effects. X1, X2, . . . , X10 are independently generated from
a standard normal distribution. Time-to-event data for each latent subgroup are generated from a Weibull
distribution. The true values of the scale parameters (i.e., λ1 and λ2) of the Weibull distributions are set to be
1 and 4.5, respectively, and the true values of the shape parameters (i.e., κ1 and κ2) are 1 and 3, respectively.
The 2-year survival probabilities are 13.5% for the high-risk group and 91.5% for the low-risk group. The
censoring time is generated from an exponential distribution, where the mean is calibrated by a pre-specified
censoring rate of 30%. The subgroup-specific survival curves are illustrated in the left plot of Figure 4.6.
Different scenarios are considered to mimic various cases in actual applications. Specifically, we consider
different functional forms for h(·). For all scenarios, we regard the high-risk group as the reference so h1(X)
is set to be 0. For scenario I.1, h2(X) is set to be a linear function,
h2(X) = 0.4 + 0.2X1 − 0.6X2 − 0.3X3.
In this scenario, the parametric mixture model is expected to have better performance since it is the true
model. For scenario I.2, we mimic the recursive partition on the covariate space to assign the risk group
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memberships by considering an indicator and interaction terms. Hence, h2(X) is set to be
h2(X) = 0.4 + 0.2I(X1 < 0.4, X3 > 0.2)− 0.6X21I(X2 > 0.1)
+ 0.2I(X3 > 0.4 or X2 < −0.2) + 0.2I(X2 < 0.4).
We expect our proposed tree-based method will outperform in this scenario because model misspecification
may be an issue in the parametric mixture model and the Cox PH model. For scenario I.3, we consider a






These settings are designed to illustrate the flexibility of our proposed tree-based method.



























































Note: The left plot illustrates the true survival curves for two latent groups. The right plot shows the
true survival curves for three latent groups.
Figure 4.6: The true survival curves for two simulation studies
We consider similar procedures for generating the baseline covariates and survival data for the simulation
study with three latent groups. Ten covariates are independently generated from a truncated standard normal
distribution from −2 to 2. Note that the truncated normal distribution is used for stabilizing numerical
computations only. The censoring rate is set at 30%. Weibull distributions for high-, medium- and low-risk
groups have true values 1, 3.3 and 7.4 for the scale parameter and 1, 2.5 and 4 for the shape parameter,
respectively. The 2-year survival probabilities are 13.5%, 75.5% and 95.5% for the high-, medium- and
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low-risk groups, respectively. The subgroup-specific survival curves are illustrated in the right panel of Figure
4.6. Three similar scenarios are considered in the simulation study for three latent groups. Nonparametric
functions h2(X) and h3(X), for the medium- and low-risk groups respectively, are linear combinations of
the baseline covariates under scenario II.1,
h2(X) = 0.9 +X1 − 0.8 ∗X2 −X3,
h3(X) = 0.6− 0.6 ∗X1 −X2 + 0.7 ∗X3.
For scenario II.2, we mimic the tree partition by setting
h2(X) = −0.5 + 0.6 ∗ I(X1 < −1 or X2 > 1)− 0.8 ∗ I(X1 > 0 and X3 > 0.2),
h3(X) = 0.5 + 0.4 ∗ I(X1 < −1 or X2 > 1) + 0.4 ∗ I(X1 > 0 and X3 > 0.2).










2 − 1) ∗ (I(X1 ≤ 0.5) + 1).
4.4.2 Simulation Results
The first step of our tree-based algorithm is to determine the number of latent groups that exist in the
data. To do this, we assume different numbers of latent groups in the data and grow a tree for each choice
of number of latent groups. The BIC with penalty on the number of levels of the tree is calculated for each
tree and then used to determine the best number of latent groups. We report the simulation results based
on 1000 replicates and consider sample sizes of 300, 500, 1000 and 2000. For the scenarios of two latent
groups, the candidate choices of the number of latent groups are 1, 2 and 3. The correct number of latent
groups is selected in over 70% of the simulated datasets when the sample size equals 300. As the sample size
increases to 1000, the number of latent subgroups is correctly selected for almost 90% of the replicates. For
the scenarios of three latent groups, the candidate choices of the number of latent groups range from 1 to 4.
BIC can pick the right number of latent groups from around 70% of the simulated datasets when the sample
49
size is 300. The proportion increases to 80% as the sample size goes to 1000. With a sample size of 2000,
the right number of latent groups is chosen for over 94% of the simulated datasets.
Tables 4.5 and 4.6 summarize the median prediction accuracy along with median absolute deviation
(MAD) for simulation studies with two and three latent groups. The results from our proposed method
are obtained based on trees pruned by BIC. For numerical statibility, the Weibull distribution estimates are
restricted to (0, 7] for two latent groups scenarios and to (0, 15] for three latent groups scenarios, when the
Newton-Raphson algorithm is implemented. We also report the tree structures in terms of average depth
and average number of leaves. The prediction accuracy is calculated by applying the decision rule obtained
from the training set to an independently generated validation set with sample size 10, 000. The optimal





P (B = k|X)
)
. In general, the prediction accuracy increases as the sample size increases
and yields a decreasing trend in the median absolute deviation. The prediction accuracy also approaches
the optimal accuracy rate for large sample sizes. In examing the tree structures, the tree-based method
yields relatively simple trees even for some complicated scenarios, which is favorable for visualizing and
interpreting how the baseline covariates determine the survival risk group classification. For scenarios I.1 and
II.1, we assume a linear relationship in the nonparametric function h(·), that is, the parametric mixture model
is correctly specified. Therefore, the prediction accuracies from the parametric mixture model are better than
the results from the tree-based method. The results from Cox PH model with risk stratification are slightly
better than results from survival tree, which may be also due to the linear relationship in the setup of h(·).
However, for the other scenarios where the parametric mixture model is not the true model, the tree-based
method outperforms the parametric mixture model. Compared with Cox PH model with risk stratification and
survival tree, our approach also obtains better results. Survival tree, in general, performs better than Cox PH
model with risk stratification, which is reasonable because survival tree can better capture the nonparametric
relationship in h(·).
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Table 4.5: Results from the simulation study for two latent groups scenarios
Prediction accuracy Tree structure
Our approach Mixture Model Cox PH model Survival Tree
N Med. accu. Med. accu. Med. accu. Med. accu. Ave. depth Ave. no. leaves
(MAD) (MAD) (MAD) (MAD)
Scenario I.1. The optimal accuracy rate is 0.649.
300 0.590 (0.012) 0.614 (0.013) 0.592 (0.012) 0.537 (0.032) 2.79 8.03
500 0.600 (0.014) 0.627 (0.008) 0.606 (0.009) 0.588 (0.023) 3.30 10.36
1000 0.613 (0.009) 0.637 (0.006) 0.612 (0.006) 0.611 (0.011) 3.95 15.12
2000 0.623 (0.007) 0.642 (0.004) 0.618 (0.005) 0.615 (0.009) 4.44 20.90
Scenario I.2. The optimal accuracy rate is 0.668.
300 0.602 (0.012) 0.593 (0.017) 0.535 (0.015) 0.527 (0.043) 2.55 6.97
500 0.606 (0.011) 0.602 (0.011) 0.544 (0.013) 0.567 (0.040) 3.00 8.88
1000 0.620 (0.015) 0.607 (0.006) 0.553 (0.010) 0.604 (0.009) 3.76 13.68
2000 0.642 (0.012) 0.610 (0.004) 0.562 (0.007) 0.606 (0.006) 4.39 20.14
Scenario I.3. The optimal accuracy rate is 0.721.
300 0.623 (0.019) 0.561 (0.031) 0.502 (0.005) 0.586 (0.018) 3.51 10.61
500 0.664 (0.038) 0.589 (0.021) 0.506 (0.005) 0.620 (0.012) 4.28 15.35
1000 0.702 (0.010) 0.614 (0.008) 0.507 (0.005) 0.622 (0.006) 5.01 23.31
2000 0.709 (0.006) 0.619 (0.004) 0.507 (0.004) 0.627 (0.004) 5.32 29.71
Note. Mixture model: Parametric mixture model. Cox PH model: Cox PH model with risk
stratification. Med. accu.: median accuracy. MAD: median absolute deviation. Ave. Depth: average
depth. Ave. no. leaves: average number of leaves.
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Table 4.6: Results from the simulation study for three latent groups scenarios
Prediction accuracy Tree structure
Our approach Mixture Model Cox PH model Survival tree
N Med. accu. Med. accu. Med. accu. Med. accu. Ave. depth Ave. no. leaves
(MAD) (MAD) (MAD) (MAD)
Scenario II.1. The optimal accuracy rate is 0.663.
300 0.407 (0.044) 0.434 (0.098) 0.479 (0.010) 0.388 (0.088) 2.13 5.17
500 0.421 (0.034) 0.489 (0.041) 0.485 (0.007) 0.413 (0.103) 4.11 15.58
1000 0.434 (0.045) 0.550 (0.010) 0.486 (0.007) 0.469 (0.044) 4.70 23.03
2000 0.467 (0.035) 0.592 (0.006) 0.488 (0.006) 0.522 (0.025) 5.10 30.38
Scenario II.2. The optimal accuracy rate is 0.551.
300 0.484 (0.035) 0.328 (0.026) 0.177 (0.009) 0.177 (0.059) 3.81 12.61
500 0.502 (0.026) 0.340 (0.028) 0.177 (0.004) 0.191 (0.038) 4.02 15.01
1000 0.515 (0.020) 0.368 (0.020) 0.179 (0.002) 0.258 (0.018) 4.45 20.40
2000 0.523 (0.016) 0.428 (0.014) 0.187 (0.003) 0.324 (0.008) 4.92 28.10
Scenario II.3. The optimal accuracy rate is 0.611.
300 0.390 (0.035) 0.365 (0.071) 0.358 (0.004) 0.400 (0.021) 3.96 13.01
500 0.427 (0.037) 0.404 (0.050) 0.359 (0.004) 0.407 (0.022) 4.33 16.18
1000 0.473 (0.026) 0.445 (0.016) 0.359 (0.003) 0.407 (0.020) 5.15 25.20
2000 0.498 (0.015) 0.449 (0.016) 0.359 (0.004) 0.408 (0.013) 5.96 38.47
Note. Mixture model: Parametric mixture model. Cox PH model: Cox PH model with risk
stratification. Med. accu.: median accuracy. MAD: median absolute deviation. Ave. Depth: average
depth. Ave. no. leaves: average number of leaves.
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4.5 Real Data Application
We apply the proposed methodology to the IBCSG data discussed in Section 4.2 to study potential
heterogeneity of patients in terms of their survival outcomes and to investigate important variables that are
associated with such heterogeneity.
To explore the heterogeneity of patients under different therapeutic procedures, we apply our method to
the datasets of patients under each treatment. According to BIC, two latent subgroups are detected among
patients with treatment B and patients with treatment C, and no latent subgroups are identified among patients
with treatment A and treatment D. More specifically, for treatment A, the BICs for models assuming no
latent subgroup, two and three latent subgroups are calculated as 257.5, 272.1 and 1156.2 respectively. For
treatment B, the BICs for these three models are 258.2, 190.4 and 583.9. For treatment C, the BICs for these
three models are 225.0, 214.0 and 1008.2. For treatment D, the BICs for these three models are 250.0, 272.8
and 1472.2.
Our previous analysis using mixture model indicated that treatment does not have a significant effect
on the latent subgroup membership assignment. To explore the heterogeneity of patients under different
therapeutic procedures, we analyze data from patients under treatments B and C by assuming that two latent
groups exist in the data. The results are also compared with the parametric mixture model and the Cox PH
model with risk stratification by following the same procedure stated in Section 4.4. Assuming that the
survival outcomes for patients follow a Weibull distribution, for patients under treatment B, the survival
distribution estimates yield a shape parameter of 1.85 and a scale parameter of 0.34 for the high-risk group,
and a shape parameter of 1.37 and a scale parameter of 2.47 for the low-risk group. For patients under
treatment C, the survival distribution estimates yield a shape parameter of 1.79 and a scale parameter of 0.35
for the high-risk group, and a shape parameter of 1.21 and a scale parameter of 2.34 for the low-risk group.
Kaplan-Meier curves for patients under treatment B and treatment C are illustrated in upper panels of Figure
4.8. The logrank test is also employed to compare the survival distributions of the two latent groups. Note
that the logrank test, serving as an ad hoc measurement in this real data application, is our attempt to compare
the survival distributions of the two latent groups and we will not treat the logrank test as a formal test. The
results from the logrank test indicate that, for patients under treatment B and treatment C, two latent groups
have significantly different survival distributions (p-values are both smaller than 0.0001). Figure 4.7 shows
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the fitted trees for patients under treatment B and treatment C. Based on Figure 4.7, we see that for patients
under treatment B, the latent risk group membership assignment is associated with the number of positive
nodes, physical well-being, appetite, and mood. When looking at patients under treatment C, age, the number
of positive nodes, mood and perceived coping are important factors in the latent risk group membership
assignment.
Note. Left panel: decision tree for patients receiving treatment B. Right panel: decision tree curves
for patients receiving treatment C.
Figure 4.7: Decision trees for patients receiving treatment B and treatment C
To compare with the parametric mixture model, the Cox PH model with risk stratification and the survival
tree approach, we apply these methods to the same dataset and report the agreement of survival risk group
classification. For the Cox PH model with risk stratification and the survival tree approach, we use the first
quartile of the survival times obtained from the observed sample as the threshold to classify patients into high-
and low-risk groups since we cannot calculate the median survival times from the observed sample and the
classification using the first quartile of the survival times yields the highest agreement in terms of predicted
subgroup membership when comparing with our approach. As for treatment B, around 94.4% of the patients
have the same predicted risk group membership from the parametric mixture model and our tree-based
method. 48.8% of the patients are assigned to the same survival risk group when comparing the Cox PH
model with risk stratification and the tree-based method. All the patients have the same predicted survival
risk group membership when comparing the survival tree approach and our approach. For patients receiving
treatment C, there are 68.8% of the patients having the same predicted survival risk group membership
when applying the parametric mixture model and our tree-based method. Comparing the Cox PH model
with stratification and our approach, 31.2% of the patients are classified into the same risk group. For the
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comparison with the survival tree approach, 75.7% of the patients are classified into the same risk group. For
the model with treatment B, the number of positive nodes and mood have significant effects on the latent risk
group membership assignment based on results from both the parametric mixture model and the Cox PH
model with risk stratification. These two covariates are also important based on the mixture survival tree
according to the Figure 4.7. In the mixture survival tree, the first split is on the number of positive nodes
greater than 4, separating a group of 181 patients who have less than 4 positive nodes in the tumor and the rest
of the 67 patients who have more than 4 positive nodes in the tumor. A second split is made based on the value
of mood at 44.5, which means that for those with more than 4 positive nodes in the tumor, 17 of them with
mood smaller than 44.5 consist of one group and the rest of the 50 patients are thought to be similar in terms
of their survival profile. For the model with treatment C, we find that age and the number of positive nodes
are significantly associated with the latent group membership assignment in both parametric mixture model
and the Cox PH model with risk stratification, which also agrees with the finding in the mixture survival tree
as seen from Figure 4.7. The first split in the mixture survival tree is at age 39 years and the splits on the
second level are both made based on the number of positive nodes in the tumor. In the survival tree, the trees
for patients receiving treatment B and C are very similar. the first split from both trees is made based on
the number of positive nodes in the tumor smaller than 4. For patients with more than 4 positive nodes in
the tumor, the second split is made based on the value of mood at 44.5 (for patients receiving treatment B)
and 49.5 (for patients receiving treatment C). It is of greater interest to examine how these variables classify
patients into different risk groups. Although we find similar set of covariates that determines the latent risk
group membership assignment, it is difficult to detect interaction effects between covariates based on the
parametric mixture model approach and the Cox PH model. These two methods are only capable of linearly
describing the relationship between the covariates and risk groups. In contrast, the mixture survival tree
provides more direct visualization of how the baseline covariates determine different survival risk groups. For
example, there are interaction effects among the number of positive nodes, physical well-being, and appetite
when classifying patients with treatment B into different risk groups as well as interaction effects among age,
the number of positive nodes and mood when assigning risk group memberships for patients with treatment
C.
The goal for survival risk classification is to optimize the heterogeneity in survival outcome between
risk groups. From this point of view, a logrank test is performed to evaluate the difference between survival
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distributions estimated by the parametric mixture model, Cox PH model with risk stratification and the
survival tree approach to further compare these methods with the mixture survival tree. The results suggest
that for all methods with treatment B and treatment C, the two survival distributions from the high- and
low-risk groups are significantly different from each other (p-values are all < 0.05). For patients with
treatment B, the logrank test statistic has a value of 50.1 when testing the difference between the survival
distributions estimated by the mixture survival tree, and for the parametric mixture model, Cox PH model and
the survival tree approach, the corresponding test statistics are 48.8, 4.5 and 50.1, respectively. This implies
that the mixture survival tree is better at distinguishing distinct survival profiles. Similar results are also
observed in patients with treatment C. The logrank test statistics are 46.9, 15.9, 10.3 and 34.4 for the mixture
survival tree, the parametric mixture model, Cox PH model and the survival tree approach, respectively. The
Kaplan Meier curves obtained from the parametric mixture model, Cox PH model with risk stratification
and the survival tree approach are also plotted in Figures 4.8 and 4.9 to better illustrate the difference of
classification results among all methods and the difference between survival distributions for patients in high-
and low-risk groups.
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Note. Left panels: Kaplan Meier estimates from our approach and parametric mixture model (from
top to bottom) for patients receiving treatment B. Right panels: Kaplan Meier estimates from our
approach and parametric mixture model (from top to bottom) for patients receiving treatment C.
Figure 4.8: Kaplan Meier curves of high-risk and low-risk groups, predicted by our approach and
parametric mixture model, for patients receiving treatment B and treatment
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Note. Left panels: Kaplan Meier estimates from Cox PH model with risk stratification and survival
tree (from top to bottom) for patients receiving treatment B. Right panels: Kaplan Meier estimates
from Cox PH model with risk stratification and survival tree (from top to bottom) for patients
receiving treatment C.
Figure 4.9: Kaplan Meier curves of high-risk and low-risk groups, predicted by Cox PH model with
risk stratification and survival tree, for patients receiving treatment B and treatment
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4.6 Conclusion
In this chapter, we propose a tree-based algorithm to explore latent heterogeneity for patients with
different survival profiles and further classify patients into different survival risk groups. With the latent
group membership, the EM algorithm is used to model the mixing components in the data. We propose
a new splitting criterion within the framework of recursive partitioning. By optimizing the observed data
log-likelihood function in each split, we maximize the within-node homogeneity and the between-node
heterogeneity. Our proposed tree-based algorithm is capable of simultaneously estimating the unknown
survival distributions and predicting the latent subgroup membership. A simple and interpretable tree-like
structure is also presented to characterize how the baseline covariates determine the unobserved heterogeneity
in patients. The simulation studies show that our proposed method works well in various settings, especially
when the latent subgroup membership assignment depends on baseline covariates via a non-linear relationship.
Using our approach, we could directly classify patients into different risk (e.g., high vs low risk) groups
based on their survival profiles. Since the identified classes have distinct survival distributions, each class
is clinically meaningful, corresponding to patients with either long or short survival trajectories. Thus, the
obtained classes can be useful to differentiate subgroups of patients at least in the following direction. First,
the obtained latent classes can be used for patient recruitment in conducting future clinical trials. For example,
we can recruit more patients from the high-risk group to empower trials. Another potential application is as
illustrated in the real data application, our method can be used to identify a subgroup of patients who may
benefit more from one treatment as compared to the rest and to explore the baseline characteristics of this
subgroup of patients based on selected important covariates.
One possible extension of the proposed work is to study the treatment response heterogeneity in patients
within the framework of our proposed tree-based method. A semi-parametric approach can be established to
simultaneously estimate the baseline survival and treatment effects for patients by assuming that the latent
heterogeneity in patients is associated with heterogeneous survival and treatment responses.
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CHAPTER 5: RANDOM FOREST FOR SUBGROUP ANALYSIS WITH HETEROGE-
NEOUS TREATMENT RESPONSES
5.1 Introduction
The primary goal of subgroup analysis in clinical trials is to explore and estimate the heterogeneous
treatment effect across subgroups, which might be determined by the baseline patient characteristics and/or
their specific survival experience. From this point of view, subgroup analysis is fundamental to the interpreta-
tion of clinical trial results and beneficial to the development of new medicines. Significant treatment effects,
sometimes, in the whole population of clinical trials cannot be observed. Whereas substantial heterogeneity in
treatment effects would be discovered in a small group of patients, indicating that the treatment is beneficial
to a subpopulation. As known, the heterogeneity in treatment effects could be detected by recursively
partitioning the population into several subpopulations based on baseline patients characteristics and their
survival profiles. However, some statistical concerns also arise due to the low power of statistical tests in
clinical trials. In addition, the individualized treatment effect estimate may be of less interest, especially
when the sample size is not large enough. Alternatively, a stratified treatment effect is more useful. The
average treatment effect in each strata/subgroup can indicate positive or negative treatment effects, or whether
or not the treatment effect greater than clinical threshold. In this regard, stratified treatment effect estimate,
especially when a small number of latent subgroups is discovered and each latent subgroup has a distinct
treatment effect, is favorable. Additionally, such treatment effect estimate is advantageous to detect higher
power because sufficient sample is easy to obtain.
By the motivation of stratified treatment effects, we propose a random forest approach to discover latent
subgroups of patients with specific survival experience and treatment responses. The unobserved subgroup
labels for patients are treated as missing data and EM algorithm is embedded to optimize the observed data
loglikelihood function in the binary splitting of individual trees. Ensemble methods are then applied to
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combine individual trees in the forest. Variable importance measurement is developed to understand and
visualize each feature’s contribution to the model fitting.
The rest of this chapter is organized as follows, Section 5.2 describes the model set-up and algorithm
implementation of our proposed method. Section 5.3 summarizes the finite sample performance via extensive
simulation studies. Section 5.4 analyzes a phase III clinical trial of patients with hematological malignancies
using the proposed method.
5.2 Methodology
5.2.1 Mixture Survival Model
We assume that there are K different latent subgroups existing in the entire population, where each
latent subgroup corresponds to a distinct treatment effect. More specifically, each subgroup of patients follow
a specific survival profile and the difference of the survival profile among different subgroups is due to the
fact that patients from different subgroups respond to the treatment differently.
Suppose that we have the right-censored observations from n i.i.d. patients, denoted by
{Yi = Ti ∧ Ci,∆i = I(Ti ≤ Ci), Ai,Xi, i = 1, . . . , n},
where Ti denotes the time to event, Ci is the censoring time, Ai is the binary treatment assignment and the
baseline covariates are written as Xi for subject i. Assuming that the censoring time is independent of Ti
given Xi. We assume that the survival distribution of the kth group follows a Cox model,
λk(t;A,X) = λ0(t) exp(βkA+ γX),
where λ0 is the common baseline hazard rate for all subgroups, βk is the treatment effect for the kth subgroup,
and γ is the coefficient of baseline characteristics.
To classify each patient into one of the subgroups using the baseline covariates X, we introduce a latent
group membership B and assume
P (T > t|B = k,A,X) = S(t, βk,γ;A,X),
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0 λ0(u)du exp(βkA+ γX)
}
and
P (B = k|X) = exp{hk(X)}∑K
k=1 exp{hk(X)}
= gk(X)
for k = 1, . . . ,K, where hk(X) is a nonparametric function and h1(X) = 0 (set subgroup 1 as the reference
group). Therefore, the latent group membership determines which group the patient should belong to. This
membership depends on the baseline covariates through a nonparametric distribution and we could study
this nonparametric distribution by recursively partitioning the covariate space. Clearly, the proposed model
implies that the marginal survival distribution for T takes a mixture form:




To conduct a future trial, for any new patient with baseline covariates X = x, we then classify this patient
into group k with maximal value gk(X), that is, the most likely group membership.
5.2.2 Tree-based Algorithm for Model Fitting
We propose a tree-based algorithm to estimate the group classification function, gk(X), k = 1, . . . ,K.
Since the label of subgroups, B, is unknown in the data, we treat it as missing data and incorporate the EM
algorithm to handle the latency of subgroup membership. The idea of our proposed tree-based algorithm is
that the covariate space is recursively partitioned to optimize the observed data log-likelihood function and
the same subgroup membership is assigned to patients in the same subregion of the covariate space. The
splitting is stopped when only a few patients remain in the child nodes or the number of patients from either
treatment or control arm is smaller than some thresholds.
More explicitly, suppose that there are K latent subgroups in the data, we obtain the observed data
log-likelihood function


















where β = (β1, . . . , βk)T , f(t, βk,γ;A,X) = −S
′




on the data {Yi = Ti ∧ Ci,∆i = I(Ti ≤ Ci), Ai,Xi, i = 1, . . . , n}. The complete data log-likelihood is
written as





I (Bi = k) [∆i log {f(Yi, βk,γ;Ai,Xi)gk (Xi)}
+ (1−∆i) log {S(Yi, βk,γ;Ai,Xi)gk (Xi)}]
To numerically learn the nonparametric function gk(X) and to grow a decision tree, the first step is to set
the starting values for βk, k = 1, . . . ,K, γ and hk(X). The starting values for βk, k = 1, . . . ,K are chosen
to be close to 0 but have different values to guarantee the identifiability of the mixture survival model and the
starting values for γ are set to be 0. hk(X) relies on the coefficients of a weighted multinomial regression
model where more details will be discussed later in this section. The starting values for the coefficients of the
weighted multinomial regression model are chosen to be 0. For each splitting, based on the data Bt+1 in the
current node, we apply the EM algorithm.
In the E-step, the expected log-likelihood based on all parameters conditional on the observed data is
































































for i ∈ Bt+1 and k = 1, . . . ,K by using {β̂(t)k , γ̂
(t), h
(t)
2 , . . . , h
(t)
K } obtained from parent node. The baseline
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In the M-step, for each feature Xj , j = 1, . . . , p, and for each potential split x, we optimize the objective
function







ik [∆i log (f(Yi, βk,γ;Ai,Xi))
+(1−∆i) log (S(Yi, βk,γ;Ai,Xi)) + log (gk(Xij))] , (5.7)
which is equivalent to fitting a weighted multinomial regression model









exp {θ0k + θ1kI (Xij < xj)}∑K
k=1 exp {θ0k + θ1kI (Xij < xj)}
}
(5.8)
based on the current data Bt+1. To fit the weighted multinomial model (5.8), we use the one-step Newton-
Raphson update. θt+10k and θ
(t+1)






























for k = 1, . . . ,K
Next, we search for the optimal splitting variable and corresponding splitting value among the grid
points that optimize the observed data log-likelihood. An exhaustive search is performed on the features
Xj , j = 1, . . . , p and their corresponding potential splitting values x. The 20th, 30th, ..., 80th percentile of
Xj would be choices for potential splitting values x. We seek the optimal splitter {Xj′ , xj′} that maximizes
the objective function (5.8). Then, the corresponding {θ′0k, θ′1k} are calculated, and h
(t+1)
k (Xi) is updated by
h
(t+1)




1kI(Xij′ < xj′), for i ∈ Bt+1
Our proposed tree-based algorithm also estimates the survival profiles for each latent subgroups, that is,
the algorithm provides treatment effect estimate, βk, k = 1, . . . ,K, for each latent subgroup and the estimates
of baseline covariates effects, γ. To obtain these estimates, we consider the whole dataset B. After we grow
each level of the tree, we combine all the data points from the child nodes and apply the Newton-Raphson















qskI (Ys ≥ Yi) exp (βkAs + γXs)
)
+ βkAi + γXi
]
with respect to βk, k = 1, . . . ,K, and γ. This partia loglikelihood function is obtained by plugging the
baseline hazard estimate (5.6) into the objective function (5.7).
The binary splitting is stopped when each terminal node contains no more than
√
n patients or the number
of events from either treatment or control arm smaller than some thresholds (we use 5 in the simulation
studies and the real data analysis).
5.2.3 Random Forest Algorithm for Combining Individual Decision Trees
The proposed tree-based method can be further extended to random forest by applying ensemble method
(Breiman, 1996, 2001). The idea in random forest is to combine many tree predictors and average them to
reduce the variance. The random selection of features in the tree splitting process helps to further reduce
the variance by reducing the correlation between trees. Each tree in a forest is built based on a bootstrap
sample of the training data. The splitting feature at each node is determined from a subset of covariates that
are randomly selected from the covariate list to grow each tree. The trees in the forest are fully grown and
the pruning procedure is usually not implemented. So the sizes of trees are sufficiently large, the sizes of
terminal nodes are small and the trees tend to achieve a low bias. To obtain the prediction results on a future
data, each tree of the forest is applied to the data and each subject in the data obtain a predicted class label
based on majority vote results from trees in the forest.
Suppose that T = {Td}Dd=1 is a collection of D individual trees constructed based on bootstrap samples
of the original training data. Td for d = 1, . . . , D is grown by following the procedure in Section 5.2.2.
At each node, m (m < p) features are randomly selected as candidate splitting features and the optimal
one among m candidate features is selected to optimize the objective function (5.7). The binary splitting
is stopped until the stopping criterion is met. For any future subject i with baseline covariates Xi = x,
we obtain the predicted subgroup membership B̂id by applying the decision rule obtained from tree Td for




Extensive simulation studies are performed to evaluate the performance of our proposed random forest
model. We consider that two latent subgroups exist in the data. Binary treatment is considered in the
simulation studies. The treatment has a beneficial effect in one subgroup and is harmful in the other subgroup,
compared with the control group.
Ten baseline covariates, X1, X2, . . . , X10, are considered and only a few of them have nonzero effects.
Ten baseline covariates are independently generated from a standard normal distribution. The treatment
assignment is generated from Bernoulli distribution with the probability of 0.5 and takes value of −1 or
1. The baseline hazard rate is set to be a constant λ with the value of 2. Censoring times are generated
from an exponential distribution with censoring rate around 30%. The true effect of treatment in two latent
subgroups are set to be β1 = −1.5 and β2 = 1.5. Kaplan Meier curves in Figure 5.10 demonstrate the
different treatment responses in different subgroups. Different scenarios are considered to mimic various
cases in actual applications. We apply the proposed algorithm to study different functional forms for h(·).
For both scenarios, we regard group 1 as the reference group so h1(X) is set to be 0. For scenario I.1, h2(X)
is a linear combination of a few baseline covariates,
h2(X) = −0.6 + 0.4X1 − 0.2X2 + 0.5X3.
For scenario I.2, we mimic a tree structure to assign latent subgroup membership, so h2(X) is an indicator
function
h2(X) = −1 + 2I{(X1 < 0, X2 < −0.5) or (X1 ≥ 0, X3 ≥ 0.5)}.
5.3.2 Simulation Results
We report the simulation results based on 100 replicates and consider sample size of 100 and 400. The
number of trees in each forest is from 50 to 500 and the number of random features considered at each
splitting is 3 and 5. Table 5.7 summarizes the mean classification accuracy and the standard errors for the
simulation study. We calculate the classification accuracy by predicting the fitted random forest model on an
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Note: The left plot illustrates the true survival curves for two treatment arms in the group that
treatment is beneficial. The right plot shows the true survival curves for two treatment arms in the
group that treatment is harmful.
Figure 5.10: The true survival curves for two treatment arms in simulation studies of two latent
subgroups
independently generated validation set with sample size 10, 000. The optimal accuracy rate is calculated as 1




P (B = k|X)
)
. Note
that this accuracy assumes known group membership so the actual truth can be smaller than this number.
As table 5.7 indicates, the average classification accuracy shows large improvement when increasing
sample size from 100 to 400, and the standard errors also demonstrate a decreasing trend as the sample size
increases. A slowly increasing trend in average classification accuracy is observed when the number of trees
in each forest increases from 50 to 500. Little difference in classification accuracy is observed when the
number of random features considered at each splitting increase from 3 to 5.
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Table 5.7: Average classification accuracy and standard error from the simulation study
Scenario I. The optimal accuracy rate is 0.666.
N Ntree Mtry=3 Mtry=5
100 50 0.600 (0.034) 0.593 (0.034)
100 0.601 (0.034) 0.596 (0.034)
200 0.603 (0.034) 0.597 (0.035)
500 0.604 (0.035) 0.597 (0.036)
400 50 0.620 (0.017) 0.617 (0.018)
100 0.623 (0.016) 0.620 (0.012)
200 0.624 (0.017) 0.622 (0.018)
500 0.625 (0.017) 0.622 (0.018)
Scenario II. The optimal accuracy rate is 0.730.
N Ntree Mtry=3 Mtry=5
100 50 0.591 (0.039) 0.588 (0.037)
100 0.595 (0.038) 0.591 (0.037)
200 0.597 (0.039) 0.592 (0.037)
500 0.597 (0.029) 0.593 (0.038)
400 50 0.630 (0.021) 0.635 (0.023)
100 0.636 (0.021) 0.639 (0.022)
200 0.636 (0.020) 0.638 (0.014)
500 0.639 (0.020) 0.641 (0.022)
Note. Ntree: number of tree in each forest. Mtry: number of features randomly selected at each
splitting.
5.4 Real Data Application
We apply the proposed method to a Phase III randomized clinical trial data in (Lipkovich et al., 2017).
This trial recruited patients with hematological malignancies and randomly assigned patients to treatment or
control groups. Patients in treatment group received an experimental therapy plus best supporting care and
only best supporting care was provided to patients in control group. A total of 599 patients were enrolled,
303 of them were in the treatment group and the other 296 patients were in the control group. 14 baseline
covariates were recorded, including demographic characteristics, clinical variables associated with baseline
disease severity, and cytogenetic markers. More explicitly, the covariates list contains both nominal covariates
such as patient sex, race, patient’s prior therapy outcome, and nine cytogenetic markers (presence or absence),
68
and ordinal covariates such as cytogenetic category and prognostic score for myelodysplastic syndromes risk
assessment (IPSS-R score). Eight patients had missing/unknown IPSS-R score, so they were excluded for
further analysis. For the ordinal variables, cytogenetic category had five different levels: very good, good,
intermediate, poor and very poor. IPSS-R score had four levels in Lipkovich et al. (2017): low, intermediate,
high and very high. Only one patient had low IPSS-R score, so we combine low and intermediate IPSS-R
score to one level. The median follow-up time was 7.13 months and the censoring rate was 17%. The primary
endpoint in this trial was the overall survival. The hazard ratio was used to evaluate treatment effect, an
estimate of 0.85 with p-value of 0.07 for the hazard ratio was obtained from a Cox PH model including
treatment only. The Kaplan Meier curves for patients receiving two treatments are plotted in Figure 5.4 This
finding implies that the treatment does not demonstrate a significant effect in the overall population and a
subgroup analysis to explore some subpopulations with beneficial treatment effects may be useful.
Figure 5.11: Kaplan-Meier curves for each treatment
The first step to analyze this data is to determine the number of latent subgroups. We consider BIC in the
group selection and use average observed data loglikelihood to calculate BIC value. The average observed
data loglikelihood is obtained from the forest by averaging over the values of observed data loglikelihood of
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all individual trees in the forest. The BIC is calculated by










ld +K + p
)
where log(L̂ikd) is the observed data loglikelihood of tree Td, n is the number of observations in the data, ld
is the number of terminal nodes of tree Td, K and p are the number of subgroups and covariates respectively.
To use BIC criterion in the group selection, we assume that a multiple number of latent groups exists in
the data and construct a forest for each choice. The forest yields the smallest BIC is chosen as best and the
corresponding number of latent subgroups is selected. We will use this average observed data loglikelihood to
evaluate the importance of each feature variable. More details regarding the variable importance calculation
will be discussed later in this section.
The random forest is constructed based on 200 trees and 3 features are randomly selected at each node
for splitting. The first step is to determine the number of latent subgroups contained in the data. As stated in
Section 5.2, we assume that there are 0 ∼ 4 latent groups existing in the dataset, and for each choice, we
build a forest and calculate the corresponding BIC value. BIC suggests that there are 2 latent groups in the
dataset. We then explore the two latent subgroups in more details. As illustrated in Figure 5.4, for the two
latent subgroups that our proposed model identified, a significant treatment effect is detected in one group,
with the hazard ratio estimate of 0.43 and 95% CI (0.33, 0.54), which implies that the experimental treatment
is beneficial to patients in this subgroup. In the other subgroup, the treatment effect is also significant, but
on the other direction: the hazard ratio estimate is 1.37 and 95% CI is (1.05, 1.79), which suggests that the
experimental treatment is harmful to patients in this subgroup, compared with the control treatment.
Another attractive feature of random forest is the variable importance. To understand which feature
variable is important in the latent subgroup discovery, we develop an algorithm to reveal the importance of
each variable. In the context of subgroup analysis, the variable importance will provide clues that which
variable contributes most to the differences in treatment responses. Following the idea of likelihood ratio
test, we consider the tree collection T = {Td}Dd=1, which is the random forest including all p baseline
variables. We obtain the average value of observed data loglikelihood 1D
∑D
d=1 log(L̂ikd) from T. Then,
we construct forests T−j = {T −jd }
D
d=1 for j = 1, . . . , p, where each forest is built by excluding variable j.




d ) for j = i, . . . , p, are
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Figure 5.12: Kaplan Meier curves by treatment for patients in group 1 (left panel), in group 2 (right
panel)








d ) as the variable importance
of variable j for j = 1, . . . , p.
Figure 5.4 shows the variable importance of each variable. According to this figure, patient’s prior
therapy outcome, IPSS-R score, patient’s sex, cytogenetic category and patient’s race are important modifiers
for the treatment effect. Among these important variables, patient’s prior therapy outcome contributes the
most to the model fit so we also plot the distribution of this variable in the two identified subgroups to
further explore patients with which kind of characteristic experience a beneficial treatment effect. From
the top left panel of Figure 5.4, patients with failure or progress prior therapy outcome are more likely to
experience a beneficial treatment effect. In addition, patients with a very high IPSS-R score tend to experience
a beneficial treatment effect as well, as demonstrated in the top right panel of Figure 5.4. For cytogenetic
category, those with intermediate or poor cytogenetic category are likely to experience a positive treatment
effect, as shown in bottom left panel of Figure 5.4. We also observe a small increase in the average value of
observed data loglikelihood function when excluding some variables such as biomarkers Cytogen5, Cytogen4,
Cytogen9, Cytogen1, Cytogen8, Cytogen2. Such increase may be because individual trees in the forest could
be different.
The important variables such as patient’s prior therapy outcome, IPSS-R score and cytogenetic category
are also identified using other subgroup analysis methods including IT procedure and SIDES method
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(Lipkovich et al., 2017) and 5-step stratified testing and amalgamation routine (5-STAR) (Mehrotra and
Marceau West, 2020). Lipkovich et al. (2017) provide subgroup discovery results by using SIDES method
(Lipkovich et al., 2011) and IT method (Su et al., 2009). One subgroups with beneficial treatment effects are
found to be defined by cytogenetic category and IPSS-R score by these two methods. Moreover, Mehrotra
and Marceau West (2020) utilize conditional inference tree algorithm to analyze this dataset and five risk
strata are formed. A few of these risk strata demonstrate significant treatment effect relative to the control
treatment, while the other strata suggest negligible treatment effect. Some splits in the conditional inference
tree are based on cytogenetic category, IPSS-R score and patient’s prior therapy outcome.
Note. Y axis is the difference of average values of observed data loglikelihood function between the
model including all variables and the model excluding one variable. ”Priorout” is patient’s prior
therapy outcome. ”IPSS-R” is IPSS-R score. ”Cytogencat” is cytogenetic category. ”Cytogen1”,
. . . , ”Cytogen9” are nine cytogenetic markers.
Figure 5.13: Variable importance from the proposed random forest model
To further understand the relationship between the baseline covariates and predicted latent subgroup
and facilitate the latent subgroup prediction for future patients, we consider a logistic regression model
including predicted latent subgroup membership as the response variable and important baseline covariates
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identified by the random forest model as predictors. Table 5.8 reports the estimation results for the logistic
regression model parameters. All predictors are significantly associated with the latent subgroup membership
assignment. We then randomly split the data into a training set (N=400) and a testing set (N=191). The
prediction accuracy on the test set is 0.87. Figure 5.4 illustrates the ROC curve based on the logistic regression
model fit on the testing set. The corresponding AUC is 0.947. These results imply that the logistic regression
model fits the data well and the baseline covariates are predictive of the latent subgroup membership.
Table 5.8: Estimation results for the logistic regression parameters
Covariate Estimate Std. Error z value p-value
(Intercept) 0.4111 0.3124 1.3162 0.1881
Sex 2.2442 0.3700 6.0651 < 0.0001
Cytogencat 0.5743 0.1807 3.1785 0.0015
IPSS -5.8133 0.5905 -9.8452 < 0.0001
Cytogen3 1.3157 0.4277 3.0760 0.0021
Cytogen6 -2.0323 0.5203 -3.9062 0.0001
Cytogen7 -4.3313 0.6423 -6.7437 < 0.0001
Race, asian 3.9323 1.2585 3.1246 0.0018
Race, black -0.9258 0.8637 -1.0718 0.2838
Priorout, failure -6.8745 0.8206 -8.3776 < 0.0001
Priorout, relapse 2.4182 0.3943 6.1332 < 0.0001
Note. The whites is the reference group for race variable. Progress is the reference group for
patient’s prior therapy outcome.
We also apply the parametric mixture model described in Section 3.2 to this dataset, where the patient-
level treatment assignment is blinded. The variable selection procedure of the proposed parametric mixture
model is not implemented to the analysis. BIC criterion suggests that two latent groups in this dataset
and we plot the Kaplan Meier curves of two groups in the left panel of Figure 5.16. The parametric
mixture model is also used to explore latent subgroups in either treatment or control arms. Among patients
receiving experimental treatment, no latent subgroups is discovered. The survival curve for patient receiving
experimental treatment is shown in the middle panel of Figure 5.16 For the control arm, two latent subgroups
are identified by comparing BIC values of forests assuming the presence of 0 ∼ 3 latent groups. According to
the right plot of Figure 5.16, one subgroup of patients in the control arm have short-term survival, the median
survival time is around 4 months. The other subgroup of patients in the control arm demonstrate a longer
survival time with a median survival time around 10 months. This finding also agrees with our observation of
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results from the proposed random forest model in Figure 5.4. The survival curves for patients in the treatment
group (the green curves) in the middle and right plots in Figure 5.4 have similar shape, comparing with
curves of patients in the control group (the red curves). In the subgroup that treatment is beneficial, patients
receiving control treatment die fast at the beginning. While in the other subgroup, patients receiving control
treatment achieve much longer survival. This implies that the difference of treatment effects in two subgroups
identified by random forest model may be because patients respond to the control treatment very differently
in two subgroups.
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Figure 5.14: Barplots of the distributions of patient’s prior therapy outcome (top left panel), IPSS-R
score (top right panel), cytogenetic category (bottom left panel) and sex (bottom right panel)
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Figure 5.15: ROC curve based on prediction results of logistic regression model from a randomly
sampled test set
Figure 5.16: Kaplan Meier curves from parametric mixture model without treatment information, in
treatment group (left panel), in control group (right panel)
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5.5 Discussion
In this chapter, we develop a random forest model to explore latent subgroups with heterogeneous
treatment effects using survival outcomes. We assume that the survival profiles of patients are related to
baseline covariates and treatment effects. The differences among subgroups are owing to the different
treatment responses of patients from different subgroups. We learn the relationship between latent subgroup
membership and the baseline covariates by recursively partitioning the covariates space in each individual
decision tree. The unobserved subgroup membership is treated as missingness and the EM algorithm is
incorporated to handle the missing data. We apply the EM algorithm via the method of weights (Ibrahim,
1990; Lipsitz and Ibrahim, 1996, 1998), where we calculate the conditional distribution of the missing data
given the observed data and the current estimate of the parameters in E-step. The computation depends on the
complete data and the incomplete data likelihood is not required. As a result of applying the EM algorithm,
the binary splitting at each node in individual decision tree is to optimize the observed data loglikelihood
function.
An application to the data from a phase III clinical trial in patients with hematological malignancies is
provided. Our proposed method directly classifies patients into two large subgroups and discovers significant
treatment effects. Moreover, a variable importance measurement is derived to visualize the important features
that determines latent subgroup membership assignment and modify different treatment responses among
subgroups. We also provide an example demonstrating the latent subgroup prediction for future patients by
using a logistic regression model, which facilitates the understanding and interpretation of the relationship
between latent subgroup membership and baseline covariates, and enables a quick and simple implementation
for future patients latent subgroup classification.
Unlike other subgroup analysis methods, the heterogeneous treatment effects are modeled in terms of
interactions of treatment and covariates using parametric modeling, which may be insufficient to explore the
heterogeneity in complicated forms. Our proposed tree-based nonparametric approach improves the flexibility
in detecting the heterogeneity in patients’ treatment responses. In addition, some other nonparametric
subgroup analysis methods also employ recursive partition as a natural way to explore heterogeneous
treatment effects, while they consider the subgroup analysis in a post hoc manner. Many latent subgroups are
formed after the construction of model. The number of latent subgroup are determined afterwards by using
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some statistical tests to examine the heterogeneity between small subgroups and some thresholds are adopted
to combine subgroups. The choice of such threshold may be subjective and needs additional investigation. On
the other hand, our proposed method aims to reveal latent subgroups in the data with larger sample size and
no further combination is needed. So one may be more confident when conduct tests to evaluate treatment
effects. Furthermore, based on the identified subgroups and the variable importance results, one may extract
more information regarding how patients response to treatment differently. Such information potentially
helps to design a future trial or propose new research hypotheses.
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CHAPTER 6: EXTENSIONS AND FUTURE RESEARCH
6.1 Inferring Latent Heterogeneity Using Many Feature Variables with Survival Outcome
In the proposed method in Chapter 3, we assume that the survival distributions from different latent
groups are distinct, which implies that the mixture model can be identifiable. The selection on number of
latent subgroups using BIC can also help to distinguish non-identifiable cases, where BIC will suggest that
no latent subgroups exists in the data. It has been well understood that the model selection method with a
fixed number of covariates using BIC criterion (Schwarz et al., 1978) can identify the true model consistently
(Shao, 1997; Shi and Tsai, 2002). For the situation with a diverging number of covariates, the asymptotic
behavior of a slightly modified version of BIC criterion has been greatly discussed as well and the consistency
in linear regression model selection with a diverging number of covariates for penalized estimators has been
studied (Wang et al., 2009). When the number of covariates diverges in a mixture model setting, although the
BIC criterion works well in our empirical studies, we are not aware of the theoretical results of BIC criterion
in this situation. We will pursue this interesting topic in our future work.
Moreover, our proposed variable selection procedure does not cover the ultra-high dimensional case in
which the dimensionality pn is much larger than the sample size n. In this case, some problems need to be
solved. For example, the estimate of the number of latent groups based on BIC may not be consistent (Drton
and Plummer, 2017), and the variable selection procedure will be challenged (Fan et al., 2009). Further work
on applying our proposed method to ultra-high dimensional data needs to be done. This work focuses on
identifying latent groups who have a distinct survival experience. The same idea can be extended to study
latent groups who may respond to treatments differently. The latter will be particularly characterized by
different treatment effects which can be constant or time-varying. Variable selection will also be important to
determine a small list of feature variables for medical decisions. We will pursue these extensions in future
work.
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6.2 Mixture Survival Trees for Cancer Risk Classification
Some extensions from the proposed tree-based method can also be considered. In our proposed algorithm,
the survival distributions for the latent subgroups are modeled via Weibull distributions with unknown
parameters. It is easy to extend our algorithm to other parametric distributions such as the exponential
distribution and log-normal distribution. In addition, the parametric survival distribution assumption can be
further weakened, and a Cox PH model could also be considered. In addition to the survival distribution
assumptions, identifying important covariates that are associated with the survival risk group classification
is also an important issue, especially when a large number of covariates are used in the dataset. Although
the tree structure offers a straightforward explanation regarding the covariate effects, a summary statistic
reflecting the variable’s importance is still desirable. A potential direction of our future work is to incorporate
ensemble methods, such as bagging, into the current tree-based algorithm. Variable importance calculation
in a random forest can be easily applied to our algorithm and the predictive performance may be improved.
When there are a large number of covariates in the data, the proposed tree-based algorithm may be unstable
due to the sample size, and one strategy is to follow a two-step approach from Liao et al. (2020) to first select
important initial variables using machine learning techniques and then apply the selected variables to our
proposed algorithm.
6.3 Random forest for Subgroup Analysis with Heterogeneous Treatment Responses
The proposed random forest model can be extended to the following directions. First, the assumption
of common baseline hazard rate for each subgroup can be relaxed by assuming different baseline hazard
rates for different subgroups. Some kernel smooth techniques can be incorporate to facilitate the estimation
of survival distributions. The incorporation of different baseline hazard rates for different subgroups may
enable larger flexibility in dealing with unobserved heterogeneity in patients. Some diagnostic procedures
may be considered to examine the assumptions of proportional hazard model before analyzing the data.
Most diagnostic procedures are developed based on residuals such as Schoenfeld residuals (Schoenfeld,
1980, 1982), Cox-Snell residuals (Cox and Snell, 1968; Kay, 1977) and martingale residuals (Lagakos, 1981;
Barlow and Prentice, 1988; Therneau et al., 1990).
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Second, we consider that the effects of baseline covariates are the same across all subgroups in the
proposed model, which implies that the differences among subgroups only depend on different treatment
effects. The common baseline covariates coefficients assumption may be extended, resulting in a more
general model that each subgroup of patients has distinct baseline covariates coefficients. This means that the
tree splitting depends not only on different treatment effects but also on differences in the effects of baseline
covariates. An additional step may be needed to single out the partitions that are based on different treatment
effects.
Third, we consider binary treatment assignment in the proposed method. This can be extended to
multiple levels of treatment assignment, for example, in factorial experiments. Furthermore, the treatment
measured on a continuous scale, such as different doses of a new drug, can be also introduced in this proposed
method to better accommodate real world examples.
Fourth, we handle right censored data in the proposed method. The random forest model can also be
extended to deal with other types of censoring such as left censoring and interval censoring data. In addition
to the censored data, other type of outcomes can be incorporated within the framework of our proposed
random forest model.
Lastly, the primary goal of the proposed method is to explore the unobserved heterogeneity in patients’
treatment responses. The output of the proposed method is a direct classification of patients into different
subgroups, along with an estimate of average treatment effect for patients in each subgroup. As stated in
the real data application in Chapter 5, the overall treatment effect in the data may be not significant before
we discover latent subgroups. One potential direction of the future research is to develop formal statistical
tests to evaluate the overall treatment effect after adjusting for latent subgroups identified in the data on an
independent validation dataset. Furthermore, the number of events required to identify subgroups in future
trials could be determined by power and sample size calculation. The statistical testing procedure could be
also used to explore how we combine the identified subgroups for a clinically meaningful interpretation.
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APPENDIX A: TECHNICAL DETAILS FOR CHAPTER 3
Proof of Theorem 1
Set ||u|| = C, where C is a large enough constant. We need to show that for any given ε there exists a










≥ 1− ε. (6.9)

















































For I2, we first show that || 1n∇
2ln,obs(θn0) + In0(θn0)|| = op( 1pn ).
































































































By choosing a sufficiently large constant C, (6.10) and (6.12) are dominated by (6.11). Therefore, the
inequality (6.9) holds, and this completes the proof.
Proof of Theorem 2






q̃nik [∆i log f(Yi,ηk) + (1−∆i) logS(Yi,ηk) + log πk(Xi;βn)] ,
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where q̃nik are the optimal weights calculated based on the maximum likelihood estimator (η̃T , β̃T )T is
q̃nik =
(∆ifk(Yi; η̃) + (1−∆i)Sk(Yi; η̃))πk(Xi; β̃n)∑K
k=1(∆ifk(Yi; η̃) + (1−∆i)Sk(Yi; η̃))πk(Xi; β̃n)
= qnik(Yi, Xi,∆i, fk(·), Sk(·), η̃, β̃n)
To facilitate the proofs of Theorems 2 and 3, we first establish the following lemma under conditions
(C1) - (C4).
Lemma A.1. Denote the first-order derivative of ln(θn) with respect to θn byUn(θn). Then (npn)−1/2Un(θn0) =
Op(1), where Op(1) is bounded in probability.
Proof of Lemma A.1. Let












(q̃nik − qnik0) (∆i log f(Yi,ηk) + (1−∆i) logS(Yi,ηk) + log πk(Xi; θn)) .
Then we write (npn)−1/2Un(θn0) = (npn)−1/2 [Un0(θn0) + Und(θn0)].

































as n −→∞, for some M > 0, l = 1, . . . , s, j = 1, . . . , pn/K and k = 1, . . . ,K.
Therefore, we have (npn)−1/2Un0(θn0) = Op(1).





































for j, k = 1, . . . ,K.




|q̃nik − qnik0| = sup
i=1,...,n





||∇Tθnqnik(Xni, Yi,∆i, fk(·), Sk(·), θ
∗
n)|| · ||θ̃n − θn0||
−→ 0 almost surely,



























































j 6=k [∆if(Yi,ηk) + (1−∆i)S(Yi,ηk)] eβ
T



















for j, k = 1, . . . ,K and i = 1, . . . , n.
Thus, we have (npn)−1/2Und(θn0) = op(1) and it follows that (npn)−1/2Un(θn0) = Op(1).
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Proof of Theorem 2. Consider the penalized objective function
Qn(θn) = ln(θn)− n
pn∑
j=1
pλn(|βnj |) = ln(θn)− nλn
pn∑
j=1
|βnj |/|β̃nj |γ .
Since ln(θn) is essentially the likelihood of a weight multinomial regression, ln(θn) is strictly concave, and
the penalty term is strictly convex, it follows that Qn(θn) is strictly concave when n is large. Thus, there
exists a unique maximizer θ̂n of Qn(θn) for large n. Set ||u|| = C, where C is a large enough constant. It is










≥ 1− ε. (6.13)
This implies that with probability at least 1 − ε there is a local maximum θ̃n in the ball {θn0 +
√
pn(n
−1/2)u : ||u|| ≤ C}, for C > 0. Furthermore, we have












−1/2)uj |/|β̃nj |γ − |βnj0|/|β̃nj |γ
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=̂(I) + (II).
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Similar to Lemma A.1, by Chebyshev’s inequality and condition (C2), for any given ε > 0, we obtain
|| 1
n


















































































































npnλn = Op(1). (6.17)
By choosing a large enough constant C, (6.14), (6.16) and (6.17) are dominated by (6.15). Therefore,
inequality (6.13) holds, and this completes the proof.
Proof of Theorem 3
(i). To show part (i) of theorem 2, we first show that if λn → 0,
√
n/pnλn →∞ and p5n/n→ 0 as n→
∞, then with probability 1, for any given (ηT , βTn1)T satisfying ||(ηT , βTn1)T − (ηT0 , βTn10)T || = Op(
√
pn/n)
and any constant C,
Qn{(ηTβTn1, 0)T } = max
||βn2||≤C(pn/n)1/2
Qn{(ηT , βTn1, βTn2)T }.
Set εn = C
√
pn/n, then it is equivalent to show that with probability 1 as n→∞, for any (ηT , βTn1)T




, for j = qn + 1, . . . , pn, we have
∂Qn(θn)
∂βnj
< 0, for 0 < βnj < εn, (6.18)
∂Qn(θn)
∂βnj
> 0, for − εn < βnj < 0. (6.19)

































(βnl − βnl0)(βnm − βnm0)− nλn
sign(βnj)
|β̃nj |γ
=̂ I1 + I2 + I3 + I4, where θ∗n lies between θn and θn0.

































=̂ I21 + I22.
We obtain the following argument by the Cauchy-Schwarz inequality,













We have that ||βn − βn0|| = Op(
√



















In(θn0)(j, l)(βnl − βnl0)|,
where In(θn0)(j, l) is the (j, l)th element of In(θn0). By the Cauchy-Schwarz inequality and condition (C2),
we obtain













Therefore, the term I2 equals to Op(
√
npn).



























(βnl − βnl0)(βnm − βnm0)
=̂ I31 + I32.
By the Cauchy-Schwarz inequality and condition (C3), we have


























The term I32 becomes



















Combining I31 and I32, we obtain that I3 = op(
√
npn).
Recall that I1 = Op(npn), I2 = Op(
√
npn), it follows that I1 + I2 + I3 = Op(
√
npn). Since√
n/pnλn →∞ and lim infn→∞ infβ→0+ 1|β̃|γ > 0, it is clear that the sign of
∂Qn(θn)
∂βnj
is determined by the














Therefore, (6.18) and (6.19) follow. From Theorem 1, we know that Qn(θn) has a root-(n/pn)-consistent
local maximizer θ̂n. The above proof shows that part (i) holds for θ̂n = (η̂T , β̂Tn1, 0)
T , which implies that
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β̂n2 = 0 with probability tending to 1.
(ii). Let θn1 denote (ηT , βTn1, 0
T )T and θn10 denote (ηT , βTn10, 0
T )T . Since we have that P (β̂n2 = 0)→
1 obtained in part (i), we only need to consider the derivative of the asymptotic expansion of θ̂n1 in the
probability set {β̂n2 = 0}. We use a Taylor’s series expansion on∇θn1Qn(θ̂n) at θn10, which yields




(θ̂n1 − θn10)T∇3θn1 ln(θ
∗
n1)(θ̂n1 − θn10)
− bn, where θ∗n1 and θ∗∗n1 lies between θn10 and θ̂n1. (6.20)
If we have that
In(θn10)(θ̂n1 − θn10) + bn =
1
n























The last term op(AnI
− 1
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E(||Zni||2)1(||Zni|| > ε) = nE(||Zn1||2)1(||Zn1|| > ε)
≤ nE(||Zn1||4)1/2[P (||Zn1| > ε|)]1/2.
By Markov’s inequality, AnATn → G and condition (C2), it follows that
































By AnATn → G, the covariance of Zni for i = 1, 2, . . . , n can be written as
n∑
i=1
cov(Zni) = ncov(Zn1) = cov(AnI
− 1
2
n (θn10)∇θn1 ln1(θn10))→ G.





n (θn10)∇θn1 ln(θn10) asymptotically follows a
multivariate normal distribution.
Next, since θ̂n1 need to satisfy∇θn1Qn(θ̂n1) = 0, by letting the Taylor’s series expansion in (6.20) equal














(θ̂n1 − θn10)T∇3θn1 ln(θ
∗
n1)(θ̂n1 − θn10)}.
























which is implied by the Cauchy-Schwarz inequality and conditions (C3)-(C4). By Chebyshev’s inequality

















(θ̂n1 − θn10) = op(1/
√
n). (6.23)
Combining (6.22) and (6.23), it follows that (6.21) holds, and this completes the proof of Theorem 3.
Additional simulation results
Additional results for simulation scenario 2 and 3
Tables A.1 and A.2 report the accuracy of nonzero coefficient post-selection estimates, their standard
errors (SE), the mean of standard error estimator (SEE) and the coverage probability for nominal 95%
confidence interval (CP) from the simulation study scenarios 2 and 3. To obtain the standard errors for the
maximum likelihood estimates, we use the Louis formula (Louis, 1982) because the latent group membership
is treated as missing data in our method. The post-selection estimates are biased on small samples and
the bias can be greatly reduced by increasing the sample size. The 95% confidence intervals for the post-
selection estimators based on the estimated coefficients and standard errors have accurate coverage for the
true parameters.
Sensitivity analysis
In this sections, we show the results of simulation studies that evaluate the model performance when the
link function in the multinomial distribution of the latent group membership assignment is nonlinear. The
assumptions regarding the baseline covariates, the time to event data for each latent subgroup, the censoring
time and the true values of regression coefficients are the same as scenario 1 in the simulation study. In this
setting, we write the probability that one patient belongs to a specific latent group given baseline covariates as
P (B = k|X) = exp{hk(X)}∑K
k=1 exp{hk(X)}
= πk(X,β), for k = 1, 2




Table A.3 reports the classification accuracy, along with standard errors, for models without and after
variable selection when the model is misspecified. The classification accuracy is calculated by applying the
decision rule obtained from the training set to a validation set with sample size 10, 000. For both scenarios
that the model is misspecified, the classification accuracy is increasing as the sample size increases. The
accuracy is also improved after performing variable selection. Compared to the optimal accuracy rate, our
method performs reasonably well.
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Table A.1: Maximum likelihood Estimates after variable selection, their standard errors, and
coverage probabilities for nominal 95% confidence intervals from simulation scenario 2
N Parameter Bias SE SEE CP
300 k1 0.028 0.111 0.095 0.919
λ1 0.028 0.264 0.173 0.757
k2 0.061 0.390 0.272 0.867
λ2 -0.012 0.251 0.154 0.876
β0 0.003 0.702 0.346 0.809
β1 0.031 0.441 0.175 0.563
β2 -0.189 0.772 0.280 0.774
β3 -0.097 0.568 0.234 0.726
β4 0.127 0.777 0.253 0.716
β5 -0.166 0.561 0.271 0.868
β6 0.304 0.806 0.331 0.890
β7 -0.278 0.676 0.326 0.911
β8 0.212 0.637 0.282 0.902
1000 k1 0.008 0.057 0.055 0.932
λ1 0.002 0.125 0.110 0.881
k2 0.014 0.154 0.151 0.948
λ2 -0.006 0.092 0.087 0.935
β0 0.017 0.173 0.159 0.910
β1 -0.016 0.132 0.082 0.754
β2 -0.021 0.123 0.113 0.943
β3 -0.002 0.114 0.103 0.936
β4 0.011 0.125 0.111 0.939
β5 -0.022 0.115 0.108 0.944
β6 0.034 0.120 0.116 0.943
β7 -0.027 0.128 0.116 0.928
β8 0.024 0.117 0.108 0.936
3000 k1 0.003 0.032 0.032 0.947
λ1 0.003 0.071 0.067 0.925
k2 0.008 0.091 0.088 0.947
λ2 0.001 0.056 0.051 0.929
β0 -0.001 0.096 0.093 0.944
β1 -0.001 0.063 0.056 0.934
β2 -0.007 0.064 0.063 0.951
β3 -0.003 0.062 0.060 0.944
β4 0.003 0.063 0.063 0.941
β5 -0.003 0.061 0.060 0.947
β6 0.007 0.063 0.064 0.962
β7 -0.005 0.063 0.064 0.962
β8 0.005 0.063 0.060 0.939
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Table A.2: Maximum likelihood Estimates after variable selection, their standard errors, and
coverage probabilities for nominal 95% confidence intervals from simulation scenario 3
N Parameter Bias SE SEE CP
300 k1 0.037 0.118 0.098 0.907
λ1 -0.051 0.218 0.161 0.767
k2 -0.024 0.378 0.258 0.824
λ2 -0.063 0.258 0.152 0.836
β0 0.247 0.547 0.338 0.773
β1 0.041 0.373 0.187 0.568
β2 -0.139 0.541 0.256 0.709
β3 -0.101 0.446 0.225 0.691
β4 0.120 0.494 0.242 0.680
β5 -0.172 0.428 0.267 0.835
β6 0.262 0.517 0.304 0.856
β7 -0.303 0.546 0.317 0.871
β8 0.200 0.376 0.269 0.886
1000 k1 0.008 0.056 0.054 0.926
λ1 0.008 0.133 0.109 0.873
k2 0.021 0.164 0.151 0.928
λ2 -0.000 0.095 0.087 0.919
β0 0.004 0.193 0.160 0.893
β1 -0.014 0.129 0.085 0.774
β2 -0.027 0.138 0.114 0.934
β3 -0.015 0.117 0.107 0.942
β4 0.024 0.128 0.114 0.938
β5 -0.039 0.122 0.110 0.934
β6 0.045 0.132 0.118 0.932
β7 -0.050 0.136 0.119 0.922
β8 0.031 0.119 0.110 0.947
3000 k1 0.002 0.032 0.032 0.946
λ1 0.004 0.072 0.067 0.920
k2 0.005 0.091 0.088 0.943
λ2 -0.000 0.054 0.051 0.941
β0 -0.000 0.095 0.093 0.937
β1 -0.000 0.065 0.056 0.936
β2 -0.003 0.066 0.063 0.942
β3 -0.009 0.062 0.060 0.945
β4 0.008 0.063 0.063 0.953
β5 -0.002 0.062 0.060 0.938
β6 0.006 0.067 0.064 0.942
β7 -0.006 0.066 0.064 0.944
β8 0.005 0.061 0.060 0.944
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Table A.3: Results from the sensitivity analysis
Accuracy (SE)
without after
N variable selection variable selection
The optimal accuracy rate is 0.726.
300 0.562 (0.046) 0.594 (0.056)
1000 0.596 (0.038) 0.609 (0.043)
3000 0.618 (0.013) 0.620 (0.004)
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APPENDIX B: TECHNICAL DETAILS FOR CHAPTER 4
Proof of Theorem 1
We write the complete data log-likelihood as





I(Bi = k) [∆i log {f(Yi; ηk)gk(Xi)}
+(1−∆i) log {S(Yi; ηk)gk(Xi)}] .
To show that the observed data log-likelihood increases in successive iterations, we calculate the
difference in the observed data log-likelihood between two successive iterations as
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where Lc(·) = exp{lc(·)} is the complete data likelihood function.
The inequality above holds according to Jensen’s inequality. A similar argument for dataset B(t+1)2 can
be easily obtained. Therefore, (II) is non-positive, which implies that the observed-data likelihood function
increases over successive iterations.
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